antibodyId,targetAntigen,hostOrganism,clonality,cloneId,uniprotId,reactiveSpecies,conjugate,_pmid,_doi,_publicationTitle,_foundIn,_confidence,_contextSnippet,_whyMissed,_reasoning,_source,_completenessScore,_criticalFieldsScore,_missingCriticalFields,_hasMinimumFields
dd973202-a403-4c44-9556-2567e1a4129e,NF2 antibody,,,,,,,PMID:11756419,,Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.,methods,0.95,"primary (Cell Signaling Technology Cat# 6995, RRID:AB_10828709, 1:500)","NF2 antibody with vendor, catalog number, RRID, and dilution for immunostaining",,AI validation - Sonnet 4.5,0,0,,
9241c02c-9009-41ec-ab28-28d0321a4699,caspase 3 antibody,,,,,,,PMID:18242512,,Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.,methods,1.0,"caspase 3 (Cell Signaling Technology, cat. # 9662, RRID: AB_331439)","Antibody with vendor, catalog number, and RRID",,AI validation - Sonnet 4.5,0,0,,
e402e65f-18ff-40d4-bb82-08bdf9e4da4e,PARP-1 antibody,,,,,,,PMID:18242512,,Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.,methods,1.0,"PARP-1 (Cell Signaling Technology, cat. # 9542, RRID: AB_2160739)","Antibody with vendor, catalog number, and RRID",,AI validation - Sonnet 4.5,0,0,,
846c643a-6354-4f6d-9876-028f7dcf7542,GAPDH antibody,,,,,,,PMID:18503770,,The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors.,methods,0.95,"GAPDH (60004-I-Ig, Proteintech, China)",Antibody with catalog number and vendor information,,AI validation - Sonnet 4.5,0,0,,
9f1910f1-f614-41cd-8453-3dd63210449e,KITLG antibody,,,,,,,PMID:18503770,,The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors.,methods,0.95,"KITLG (sc-13126, Santa Cruz, USA)",Antibody with catalog number and vendor information,,AI validation - Sonnet 4.5,0,0,,
7e6ac80b-da67-46d3-a160-82fe3e2f3d28,phospho-p42/44 (pERK1/2) #9102 Cell Signaling,,,,,,,PMID:18671844,,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,methods,1.0,"For Western blot analysis, membranes were probed with the following antibodies: phospho-p42/44 (pERK1/2) #9102 Cell Signaling (diluted 1:1000)",This is a specific antibody with catalog number and vendor information,,AI validation - Sonnet 4.5,0,0,,
886880ea-99f4-4167-9fa7-32b42af5824e,p44 (ERK1) #4372 Cell Signaling,,,,,,,PMID:18671844,,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,methods,1.0,p44 (ERK1) #4372 Cell Signaling (diluted 1:1000),This is a specific antibody with catalog number and vendor information,,AI validation - Sonnet 4.5,0,0,,
0f1400ba-5d1c-4aa2-8a25-3fe6ea30313d,S100 protein antibody,,,,,,,PMID:18769552,,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,methods,0.95,"Immunostaining with S100 protein (rabbit polyclonal, Dako, Carpenteria, Calif, USA) and KIT (rabbit polyclonal, Dako) was performed when necessary to confirm diagnosis.",Specific antibody with vendor information (Dako) and species (rabbit polyclonal) clearly mentioned,,AI validation - Sonnet 4.5,0,0,,
7b0e5cf9-e089-4251-a60e-4b3e6bec0182,KIT antibody,,,,,,,PMID:18769552,,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,methods,0.95,"Immunostaining with S100 protein (rabbit polyclonal, Dako, Carpenteria, Calif, USA) and KIT (rabbit polyclonal, Dako) was performed when necessary to confirm diagnosis.",Specific antibody with vendor information (Dako) and species (rabbit polyclonal) clearly mentioned,,AI validation - Sonnet 4.5,0,0,,
3ffb7223-e685-4474-987f-762cd0152297,anti-EGFR antibody (31G7),,,,,,,PMID:18769552,,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,methods,0.98,"For mouse monoclonal anti-EGFR (31G7, Zymed, South San Francisco, Calif, USA, final dilution 1/10), P53 (DO-7, Novocastra, Newcastle upon Tyne, UK, final dilution 1/50)","Specific antibody clone (31G7) with vendor (Zymed), species (mouse monoclonal), and dilution specified",,AI validation - Sonnet 4.5,0,0,,
57106995-2a4f-436e-8cff-f4a6ee61b030,P53 antibody (DO-7),,,,,,,PMID:18769552,,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,methods,0.98,"For mouse monoclonal anti-EGFR (31G7, Zymed, South San Francisco, Calif, USA, final dilution 1/10), P53 (DO-7, Novocastra, Newcastle upon Tyne, UK, final dilution 1/50)","Specific antibody clone (DO-7) with vendor (Novocastra), dilution specified",,AI validation - Sonnet 4.5,0,0,,
6a8e6b2d-f762-4f6d-9375-89e1ef22a6bf,anti-Ki-67 antibody (Mib1),,,,,,,PMID:18769552,,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,methods,0.98,"and anti-Ki-67 (Mib1 Dako, final dilution 1/50), staining was revealed with LSAB kit (Dako).",Specific antibody clone (Mib1) with vendor (Dako) and dilution specified,,AI validation - Sonnet 4.5,0,0,,
9ec1f851-4ef3-457d-863e-98dbdadd6bed,anti-S100,,,,,,,PMID:19434310,,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,abstract,0.95,Histopathological examination was completed by the immunohistochemical examination using anti-S100 and anti-vimentin antibodies,Standard antibody naming convention not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
e2c345d1-fdb6-4ff2-b5d0-43f67fb8508a,anti-CD34,,,,,,,PMID:19434310,,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,abstract,0.95,"anti-vimentin antibodies, anti-CD34, anti-CD57 and anti-neurofilament antibodies",Standard antibody naming convention not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
b9801212-881f-44d6-a779-466e19f54b3b,Ki67,,,,,,,PMID:19434310,,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,abstract,0.95,"anti-neurofilament antibodies, as well as the Ki67 proliferation marker",Proliferation marker naming not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
6309026c-4512-43ac-894f-2eb5cf526849,CD117,,,,,,,PMID:19434310,,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,methods,0.98,CD117 Abcam (ab32363) 1:100 Identifying mast cells within the tumor,Antibody with catalog number and vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
265a6eb0-1680-4393-b147-f80ec37dd2be,CD44,,,,,,,PMID:19434310,,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,methods,0.98,CD44 SensiStainTM ( HY000056 ) 1:100 Assessing growth and infiltrative pattern of the tumor,Antibody with catalog number and vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
25bcd5ef-7bc3-47f0-8381-f57672963928,Ki-67,,,,,,,PMID:19434310,,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,methods,0.98,Ki-67 SensiStainTM ( HY000157 ) 1:100 Proliferation index (PI) measuring the mitotic activity,Proliferation marker with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
4f630252-3f82-4993-be09-4bae60542690,rabbit antisera to NF1-GRD,,,,,,,PMID:1946460,,Identification and characterization of the neurofibromatosis type 1 protein product.,abstract,0.95,We have raised rabbit antisera to a bacterially synthesized 48-kDa peptide corresponding to the GAP-related domain of NF1 (NF1-GRD). These antisera immunoprecipitated the NF1-GRD peptide,The mining system may not have recognized 'rabbit antisera' as equivalent to 'antibody' - this is a legitimate antibody reagent that was developed and characterized in this study,,AI validation - Sonnet 4.5,0,0,,
1abd6bdb-00e3-4a4d-bb0b-aaba2891cc39,anti-SOX9,,,,,,,PMID:20049725,,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,methods,1.0,"probed membranes with anti-SOX9 (Santa Cruz Biotechnology, Santa Cruz, CA; 1:700)",Antibody with vendor information not recognized,,AI validation - Sonnet 4.5,0,0,,
63e5b716-596a-4c8c-b083-819fe356c899,polyclonal anti-SOX9 antibody,,,,,,,PMID:20049725,,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,methods,1.0,"We performed SOX9 immunohistochemistry on formalin-fixed, paraffin-embedded sections with polyclonal anti-SOX9 antibody (Abcam, Cambridge, UK)",Polyclonal antibody with vendor not recognized,,AI validation - Sonnet 4.5,0,0,,
5890f571-23a2-499b-976a-109cede7381b,anti-total ERK1/2 antibodies,,,,,,,PMID:20200958,,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,methods,1.0,"...Western blot analyses were performed using anti-total and anti-phospho Erk1/2 (Cell Signaling, Danvers, MA, USA) antibodies...",Antibody with vendor information not detected by current patterns,,AI validation - Sonnet 4.5,0,0,,
3881c238-9eed-41fd-b127-073e6d3c1152,anti-phospho ERK1/2 antibodies,,,,,,,PMID:20200958,,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,methods,1.0,"...Western blot analyses were performed using anti-total and anti-phospho Erk1/2 (Cell Signaling, Danvers, MA, USA) antibodies...",Phospho-specific antibody with vendor information not detected,,AI validation - Sonnet 4.5,0,0,,
33a3a483-7175-4f74-ba7f-11691112d6dd,CD68 antibody,,,,,,,PMID:21157378,,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,abstract,0.9,"...resident brain microglia (CD11b+, CD68+, Iba1+, CD45low cells) can be ablated...",Immunohistochemical marker for macrophages/microglia - antibody tool,,AI validation - Sonnet 4.5,0,0,,
6d7dff12-1361-487e-9fe4-693dfc3860c0,Iba1 antibody,,,,,,,PMID:21157378,,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,abstract,0.9,"...resident brain microglia (CD11b+, CD68+, Iba1+, CD45low cells) can be ablated...",Immunohistochemical marker for microglia - antibody tool,,AI validation - Sonnet 4.5,0,0,,
55381c90-3530-42c9-88fa-5562c682e56f,CD45 antibody,,,,,,,PMID:21157378,,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,abstract,0.9,"...resident brain microglia (CD11b+, CD68+, Iba1+, CD45low cells) can be ablated...",Immunohistochemical marker for immune cells - antibody tool,,AI validation - Sonnet 4.5,0,0,,
532a6b6f-305e-4017-849e-32742e9fd331,S100β,,,,,,,PMID:22550514,,Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.,abstract,0.8,...a nullizygous population of cells that is S100β negative is present in human neurofibromas...,"Cellular marker used for identification/characterization, likely antibody-based detection",,AI validation - Sonnet 4.5,0,0,,
a32235da-c555-4025-9e1c-fdf93ba753d7,pS6 antibody,,,,,,,PMID:24509877,,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,methods,1.0,"...Tumor paraffin sections stained for MAF (Imgenex), pS6, pERK (Cell Signaling)...",Phospho-specific antibody not recognized,,AI validation - Sonnet 4.5,0,0,,
58b45780-d35a-47c5-a02c-dc33db74d7ab,S100β antibody,,,,,,,PMID:24509877,,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,methods,1.0,"...Primary antibodies used were S100β (Dako), MBP (Chemicon), and BLBP (Millipore)...",Antibody with vendor information not recognized,,AI validation - Sonnet 4.5,0,0,,
72062176-44a9-4664-8b6c-a409b6ed156b,MBP antibody,,,,,,,PMID:24509877,,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,methods,1.0,"...Primary antibodies used were S100β (Dako), MBP (Chemicon), and BLBP (Millipore)...",Antibody with vendor information not recognized,,AI validation - Sonnet 4.5,0,0,,
047ce2a5-52df-45b9-9cd6-ab060e9cf5a0,SOX9 antibody,,,,,,,PMID:24509877,,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,methods,1.0,"...Membranes were probed with antibodies for MAF (Imgenex), SOX9 (Santa Cruz), S100β (Dako)...",Antibody with vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
20b12ae7-6a90-404d-be53-c231baaaaba5,cleaved-caspase 3 antibody,,,,,,,PMID:24509877,,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,methods,1.0,"...DEPTOR (Novus), cleaved-caspase 3, pS6, S6, p4E-BP1, 4E-BP1, p473AKT, AKT, and β-ACTIN (Cell Signaling)...",Apoptosis marker antibody not recognized,,AI validation - Sonnet 4.5,0,0,,
e1568e18-098d-4d38-8416-66a1bc8737f3,Ki67,,,,,,,PMID:24558021,,Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.,methods,0.9,...correlation between the expression and activity of signaling pathways and proliferation of tumor cells using Ki67 marker was investigated by reverse-phase protein array...,"Ki67 is a well-known proliferation marker antibody used in immunohistochemistry and protein arrays, but may not have been recognized as an antibody tool",,AI validation - Sonnet 4.5,0,0,,
e01044fd-0044-460b-8662-ed21846638dd,guinea-pig anti-Merlin,,,,,,,PMID:24595234,,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,methods,1.0,...guinea-pig anti-Merlin [8] was used at 1∶5000...,Primary antibody with dilution - specific antibody reagent,,AI validation - Sonnet 4.5,0,0,,
6a24768b-27b6-4cf8-9c39-350f5812e827,rabbit anti-Gapdh,,,,,,,PMID:24711647,,ADAP2 in heart development: a candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome.,methods,1.0,"rabbit anti-Gapdh (14C10), rabbit anti-α-tubulin (2144S), anti-rabbit HRP-linked (7074S) and anti-mouse HRP-linked (7076S) were purchased from Cell Signaling",Primary antibody with catalog number and vendor - should be detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
28acc9eb-04b5-4629-909d-0a090375b99b,cleaved caspase-3 antibody,,,,,,,PMID:24817309,,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,methods,1.0,"Apoptosis was determined by counting the percent of cleaved caspase-3+ cells (1:500 dilution; Cell Signaling Technology, Beverly MA)",Antibody with specific vendor and dilution information not captured,,AI validation - Sonnet 4.5,0,0,,
887881cd-dfe3-492c-b6d0-e5ba652894d7,anti-EGFR antibody,,,,,,,PMID:25043298,,Oncogenic role of Merlin/NF2 in glioblastoma.,methods,1.0,"Rabbit anti-EGFR, Notch1 (Cell Signaling), and rabbit anti S518-Merlin (Abcam and Cell Signaling) were used at 1:1000 dilution",Antibody with vendor information not recognized by patterns,,AI validation - Sonnet 4.5,0,0,,
6c185d19-55df-4d77-93db-c17c97f9879a,anti-S518-Merlin antibody,,,,,,,PMID:25043298,,Oncogenic role of Merlin/NF2 in glioblastoma.,methods,1.0,"Rabbit anti-EGFR, Notch1 (Cell Signaling), and rabbit anti S518-Merlin (Abcam and Cell Signaling) were used at 1:1000 dilution",Phospho-specific antibody with vendor information not recognized,,AI validation - Sonnet 4.5,0,0,,
30945ffa-8ece-4836-92fd-89d759a90905,anti-GAPDH antibody,,,,,,,PMID:25043298,,Oncogenic role of Merlin/NF2 in glioblastoma.,methods,1.0,"Markers for membrane, cytosolic and nuclear fractions were: rabbit anti- Na + , K + - ATPase, GAPDH, and PARP (Cell Signaling) respectively",Loading control antibody not recognized,,AI validation - Sonnet 4.5,0,0,,
9d3015f3-af2f-4611-ba08-1cfffb5eba41,anti-PARP antibody,,,,,,,PMID:25043298,,Oncogenic role of Merlin/NF2 in glioblastoma.,methods,1.0,"Markers for membrane, cytosolic and nuclear fractions were: rabbit anti- Na + , K + - ATPase, GAPDH, and PARP (Cell Signaling) respectively",Nuclear marker antibody not caught,,AI validation - Sonnet 4.5,0,0,,
15599df4-6f6b-4555-b939-c821eb72f1d1,GFAP antibody,,,,,,,PMID:25535838,,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,methods,1.0,"GFAP (1:2000, rabbit, DAKO, Carpinteria, CA)",Commercial antibody with vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
8925399b-6c6b-4f8e-87e3-44ef302df0bc,Ki-67 antibody,,,,,,,PMID:25535838,,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,methods,1.0,"Ki-67 (1:500, mouse, BD Pharmingen)",Proliferation marker antibody not detected,,AI validation - Sonnet 4.5,0,0,,
745357cd-20d4-4520-be32-4e03285f037e,p-Erk antibody,,,,,,,PMID:25535838,,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,methods,1.0,"p-Erk (1:200, rabbit, Cell Signaling, Beverly, MA)",Phospho-specific antibody not detected,,AI validation - Sonnet 4.5,0,0,,
f3833eaa-7cdd-43f5-be44-f655add6462f,p-S6 antibody,,,,,,,PMID:25535838,,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,methods,1.0,"p-S6 (1:1000, rabbit, Cell Signaling)",Phosphorylation-specific antibody not captured,,AI validation - Sonnet 4.5,0,0,,
266ddae2-9f45-430e-a10f-ff562ff82c54,S100 antibody,,,,,,,PMID:25851896,,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,methods,0.95,"...slides were double immunostained with antibodies against S100 (specific to Schwann cells) and CD90 (specific to fibroblasts). For Schwann cell staining, cells were incubated with 2 μg/mL rabbit anti-human S100 antibody (DAKO, Glostrup, Denmark)...","Clear antibody mention with vendor information (DAKO) and catalog details, used for immunostaining",,AI validation - Sonnet 4.5,0,0,,
1fa71203-470c-4aa9-812e-80c287e8ef8e,phospho-S6 (S240/244) antibody,,,,,,,PMID:26219339,,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,methods,1.0,"Antibodies for phospho-S6 (S240/244), S6, phospho-p70 S6K (T389), p70 S6K, phospho-Akt (S473), Akt, phospho-NDRG1 (T346), SGK1, phospho-PAK1 (S144), PAK1, and 4EBP1 were from Cell Signaling Technology",Antibody list not parsed properly,,AI validation - Sonnet 4.5,0,0,,
9cf5d2f5-64b4-4efd-89c2-029dc16ebc0c,S6 antibody,,,,,,,PMID:26219339,,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,methods,1.0,"Antibodies for phospho-S6 (S240/244), S6, phospho-p70 S6K (T389), p70 S6K, phospho-Akt (S473), Akt, phospho-NDRG1 (T346), SGK1, phospho-PAK1 (S144), PAK1, and 4EBP1 were from Cell Signaling Technology",Antibody list not parsed properly,,AI validation - Sonnet 4.5,0,0,,
61c84b0a-ebaf-48d6-bae5-f504a37dcad9,phospho-p70 S6K (T389) antibody,,,,,,,PMID:26219339,,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,methods,1.0,"Antibodies for phospho-S6 (S240/244), S6, phospho-p70 S6K (T389), p70 S6K, phospho-Akt (S473), Akt, phospho-NDRG1 (T346), SGK1, phospho-PAK1 (S144), PAK1, and 4EBP1 were from Cell Signaling Technology",Antibody list not parsed properly,,AI validation - Sonnet 4.5,0,0,,
616c2fbc-ea73-4d0d-895f-7807c1a73a63,p70 S6K antibody,,,,,,,PMID:26219339,,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,methods,1.0,"Antibodies for phospho-S6 (S240/244), S6, phospho-p70 S6K (T389), p70 S6K, phospho-Akt (S473), Akt, phospho-NDRG1 (T346), SGK1, phospho-PAK1 (S144), PAK1, and 4EBP1 were from Cell Signaling Technology",Antibody list not parsed properly,,AI validation - Sonnet 4.5,0,0,,
4034f6da-4c9d-464d-afe9-40b266f3493c,4EBP1 antibody,,,,,,,PMID:26219339,,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,methods,1.0,"Antibodies for phospho-S6 (S240/244), S6, phospho-p70 S6K (T389), p70 S6K, phospho-Akt (S473), Akt, phospho-NDRG1 (T346), SGK1, phospho-PAK1 (S144), PAK1, and 4EBP1 were from Cell Signaling Technology",Antibody list not parsed properly,,AI validation - Sonnet 4.5,0,0,,
7ea2e5bd-feba-4750-a9bc-0cf54ec09662,GAPDH antibody,,,,,,,PMID:26219339,,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,methods,1.0,"Other antibodies included NDRG1 (Abcam; Cambridge, MA), Rac1 (BD Biosciences; San Jose, CA), GAPDH (EMD Millipore)",Antibody with vendor information not detected,,AI validation - Sonnet 4.5,0,0,,
1e485857-3914-400f-a1db-00c31b101404,NF2 polyclonal C26 antibody,,,,,,,PMID:26219339,,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,methods,1.0,the NF2 polyclonal C26 antibody has been described,Custom antibody name not recognized,,AI validation - Sonnet 4.5,0,0,,
764e4559-7c56-4dcf-a4fd-eb8e571ff32e,S100B antibody,,,,,,,PMID:26657314,,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,methods,0.9,The schwannomatosis cell lines were stained with S100B antibodies to confirm Schwann cell identity,Antibody mentioned without specific vendor/catalog information,,AI validation - Sonnet 4.5,0,0,,
d10934f7-5e33-4b3f-a366-f547c9a2e036,Merlin antibody,,,,,,,PMID:28126595,,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,methods,1.0,"The antibodies used in the study included: Merlin (1:1000), pMerlin (1:500), HDAC1 (1:1000) and PDLIM2 (1:500) from Cell Signaling Technology",Antibody with dilution and vendor information not caught,,AI validation - Sonnet 4.5,0,0,,
a0ccafb6-a068-4220-81fa-d8bb4c304add,GAPDH antibody,,,,,,,PMID:28126595,,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,methods,1.0,GAPDH (1:50.000) from Millipore,Loading control antibody with vendor not caught,,AI validation - Sonnet 4.5,0,0,,
fcd156d6-4a34-4dd5-81eb-caffa096a84c,anti-NF1 D7R7D,,,,,,,PMID:28166733,,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,methods,0.95,"anti-NF1 D7R7D #14624 (Cell Signaling, rabbit, 2% BSA, 1:1000, overnight, 4°C)",Primary antibody used for NF1 protein detection in western blotting,,AI validation - Sonnet 4.5,0,0,,
d7cd80a5-aa91-429a-8360-cbed94e16b7d,anti-EGFR D38B1,,,,,,,PMID:28166733,,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,methods,0.9,"anti-EGFR D38B1 #4267 (Cell Signaling, rabbit, 2% milk, 1:1000–1:2000, 1 h, RT)",Primary antibody used for EGFR protein detection,,AI validation - Sonnet 4.5,0,0,,
9a5b2ae6-0581-442c-8dc7-9f8189b72998,p-ERK 1/2 antibody,,,,,,,PMID:28166733,,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,methods,0.9,"p-ERK ½ (p44/42 MAPK) #9101 (Cell Signaling, rabbit, 2% BSA, 1:2000, overnight, 4°C)",Primary antibody used for phospho-ERK detection,,AI validation - Sonnet 4.5,0,0,,
faa10276-dad9-473c-8474-0479635d76be,SUZ12 D39F6,,,,,,,PMID:28166733,,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,methods,0.9,"SUZ12 D39F6 #3737 (Cell Signaling, rabbit, 2% milk, 1:1000, overnight, 4°C)",Primary antibody used for SUZ12 protein detection,,AI validation - Sonnet 4.5,0,0,,
a62cb8d8-9c2b-4bce-ab34-d42018133036,Olig2 antibody,,,,,,,PMID:28525381,,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,methods,0.9,"using specific antibodies (Supplementary Table 1), followed by either Alexa-Fluor-tagged secondary antibodies","Antibody mentioned in supplementary table reference, not directly in text",,AI validation - Sonnet 4.5,0,0,,
37a825e3-837f-45fd-b2e1-603dc5e85c6f,GFAP antibody,,,,,,,PMID:28525381,,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,results,0.9,harbor both glial fibrillary acidic protein (GFAP)- and Olig2-immunoreactive cells,Antibody usage implied by immunoreactive staining but not explicitly stated as antibody,,AI validation - Sonnet 4.5,0,0,,
174f9bbc-c6d4-4ef7-9f53-c06af9e59f7e,S100β antibody,,,,,,,PMID:28525381,,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,results,0.9,reveal EGFP+/S100β+ glia,Antibody usage implied by immunostaining but not explicitly stated,,AI validation - Sonnet 4.5,0,0,,
e8ce928a-ca0e-42e8-905d-401bcf32e31c,Ki67 antibody,,,,,,,PMID:28525381,,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,results,0.9,proliferation (Ki67+ cells) were not observed relative to control littermates,Antibody usage implied by Ki67+ staining,,AI validation - Sonnet 4.5,0,0,,
7b3343a1-dc53-46a8-9e64-9c5c400e3333,Iba1 antibody,,,,,,,PMID:28525381,,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,results,0.9,increased Iba1+ microglia and proliferation (Ki67+ cells),Antibody usage implied by Iba1+ staining,,AI validation - Sonnet 4.5,0,0,,
26162890-4ea5-4177-9c05-6c2d387567c1,Sox2 antibody,,,,,,,PMID:28525381,,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,results,0.9,contained EGFP+ cells that co-labeled with S100β or Sox2,Antibody usage implied by co-labeling,,AI validation - Sonnet 4.5,0,0,,
14fbe0dc-ff12-458f-83da-a1aac247ec66,activated caspase-3,,,,,,,PMID:28846462,,Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.,abstract,0.95,"...we used formalin-fixed tissues (human and pigs) to evaluate select immunohistochemical markers (activated caspase-3, allograft inflammatory factor-1...",Specific antibody marker mentioned in experimental context but not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
ca3dc103-94d6-4443-8404-0ecf4e2889e9,allograft inflammatory factor-1,,,,,,,PMID:28846462,,Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.,abstract,0.95,"...immunohistochemical markers (activated caspase-3, allograft inflammatory factor-1, beta-tubulin III...",Specific antibody marker mentioned in experimental context but not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
be75a973-0ca4-46d9-9ada-af9dee19b36b,S100,,,,,,,PMID:28846462,,Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.,abstract,0.95,"...proliferating cell nuclear antigen, S100, vimentin, and von Willebrand factor...",Specific antibody marker mentioned in experimental context but not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
ae2a424c-1c98-426f-b5ca-e190e5a519dd,PD-L1 antibody (clone B55),,,,,,,PMID:29137242,,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,methods,1.0,"An antibody to PD-L1 (clone B55, Sino Biological Inc., catalog number 10084-H08H) was used at a dilution factor of 1:200",Antibody clone naming pattern not captured,,AI validation - Sonnet 4.5,0,0,,
873e7e13-9b3b-4d51-8885-5ed606836e02,CD4 antibody (clone SP35),,,,,,,PMID:29137242,,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,methods,1.0,"Antibodies to CD4 (clone SP35, Cell Marque, catalog number 104R-18) and CD8 (clone 4B11, Leica Microsystems, catalog number PA0183) were used pre-diluted",CD marker antibody with clone not captured,,AI validation - Sonnet 4.5,0,0,,
ac0847b6-4122-4c7a-b64b-c096ed63d2e6,CD8 antibody (clone 4B11),,,,,,,PMID:29137242,,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,methods,1.0,"Antibodies to CD4 (clone SP35, Cell Marque, catalog number 104R-18) and CD8 (clone 4B11, Leica Microsystems, catalog number PA0183) were used pre-diluted",CD marker antibody with clone not captured,,AI validation - Sonnet 4.5,0,0,,
9ac8a0de-4e28-4609-b02d-af492e30ee65,CD45RO antibody (clone UCHL1),,,,,,,PMID:29137242,,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,methods,1.0,"Antibodies to CD56 (clone 1B6, Leica Microsystems, catalog number NCL-L-CD56-1B6) and CD45RO (clone UCHL1, Leica Microsystems, catalog number PA0146) were used pre-diluted",CD marker antibody with clone not captured,,AI validation - Sonnet 4.5,0,0,,
b22d5d87-f7ac-4966-809b-0595bcb4afbe,Phycoerythrin-Cyanine 7-conjugated anti-human PD-L1 antibody (29E.2A3),,,,,,,PMID:29137242,,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,methods,1.0,"Phycoerythrin -Cyanine 7-conjugated anti-human PD-L1 antibody (29E.2A3) (Biolegend, catalog number 329717)",Flow cytometry antibody with complex fluorophore conjugation not captured,,AI validation - Sonnet 4.5,0,0,,
3431d897-ceea-4d21-91dd-84dea76996b4,anti-GAPDH ab9485-100,,,,,,,PMID:29662612,,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,methods,1.0,"anti-GAPDH ab9485-100 (Abcam, 1:1000, overnight)",Antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
5462a7d3-4833-45a2-8c89-d1c5c29f6400,Anti-ERK1/2,,,,,,,PMID:29670214,,Restoring functional neurofibromin by protein transduction.,methods,1.0,Anti-ERK1/2 (p44/42 MAPK (Erk1/2); Cell Signaling Technology; 1:1000),Antibody with full vendor and dilution info not caught by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
92087e94-3cbf-485d-995b-1dc242b258ea,Anti-phospho ERK1/2,,,,,,,PMID:29670214,,Restoring functional neurofibromin by protein transduction.,methods,1.0,anti-phopho ERK1/2 (Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204); Cell Signaling Technology; 1:1000),Phospho-specific antibody with epitope info not detected,,AI validation - Sonnet 4.5,0,0,,
52f0f51d-337b-4607-9f1c-ab4f91f44b00,Anti-GAPDH,,,,,,,PMID:29670214,,Restoring functional neurofibromin by protein transduction.,methods,1.0,anti-GAPDH; Santa Cruz Biotechnology Inc.; 1:3000,Standard housekeeping protein antibody not caught,,AI validation - Sonnet 4.5,0,0,,
320b5a89-292b-4ea1-a53c-7697ed7ed0df,anti-Merlin,,,,,,,PMID:29715273,,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,methods,1.0,"anti-Merlin (rabbit polyclonal antibody, A-19 (sc-331) and C-18 (sc-332), 1:50; Santa Cruz, Heidelberg, Germany)",Antibody with catalog numbers not captured,,AI validation - Sonnet 4.5,0,0,,
3bc30da1-533e-4fa1-8758-bfaaa9080e84,anti-Olig2,,,,,,,PMID:29715273,,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,methods,1.0,"anti-Olig2 (mouse monoclonal antibody, 1:500; Millipore (AB9610), Darmstadt, Germany)",Antibody name pattern not recognized,,AI validation - Sonnet 4.5,0,0,,
719cc503-65a7-4b09-84e9-f38291fb653c,anti-MBP,,,,,,,PMID:29715273,,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,methods,1.0,"anti-MBP (mouse monoclonal antibody, 1:500; Chemikon (MAB384), Schwalbach, Germany)",Antibody abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
cb5e09d1-0b3a-413f-b067-0ed33b1d7e5a,anti Ki67,,,,,,,PMID:29715273,,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,methods,1.0,"anti Ki67 (15580, 1:500, Abcam, Cambridge, UK)",Proliferation marker antibody not captured,,AI validation - Sonnet 4.5,0,0,,
a317f2b9-20b2-475d-872e-82a64a0e29a8,anti phospho-Histone H3,,,,,,,PMID:29715273,,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,methods,1.0,"anti phospho-Histone H3 (pH3-Ser10, 06–570, 1:1000, Millipore, Darmstadt, Germany)",Phospho-specific antibody not recognized,,AI validation - Sonnet 4.5,0,0,,
b77ccd90-da85-43a0-bcd5-1547d819ad1c,anti-neurofibromin antibody,,,,,,,PMID:29847659,,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,methods,1.0,"anti-neurofibromin (#A300; Bethyl Laboratories, Montgomery, TX, USA)",Antibody with catalog number and vendor not captured,,AI validation - Sonnet 4.5,0,0,,
627b20f4-36be-4558-8d5b-1afb6cd06dd5,anti-phospho-Erk XP antibody,,,,,,,PMID:29847659,,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,methods,1.0,"anti-phospho-Akt XP (#4060), anti-Akt (#2938S), anti-phospho-Erk XP (#4370), anti-Erk (#4695S; Cell Signaling, Danvers, MA, USA)",Phospho-specific antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
e338aef0-c6da-436b-aa80-f009f24a2cd1,anti-Erk antibody,,,,,,,PMID:29847659,,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,methods,1.0,"anti-phospho-Akt XP (#4060), anti-Akt (#2938S), anti-phospho-Erk XP (#4370), anti-Erk (#4695S; Cell Signaling, Danvers, MA, USA)",Total protein antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
85b56015-a684-497f-aee8-5a1e8b07e3cd,anti-GAPDH antibody,,,,,,,PMID:29847659,,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,methods,1.0,"anti-GAPDH (Novus, Littleton, CO, USA)",Loading control antibody with vendor not captured,,AI validation - Sonnet 4.5,0,0,,
44fa8759-13b7-4831-8cde-4cc5348409b8,CD34/FITC (581),,,,,,,PMID:29941005,,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,methods,1.0,"...CD14/PE (M5E2, BD Biosciences, CA, USA), CD34/FITC (581, BD Biosciences), CD45/ALexa405 (HI30, Caltag Medsystems)...",Specific antibody with clone number and vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
bab65460-39ec-4da7-8896-83265f293403,CD45/ALexa405 (HI30),,,,,,,PMID:29941005,,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,methods,1.0,"...CD34/FITC (581, BD Biosciences), CD45/ALexa405 (HI30, Caltag Medsystems), CD90/PECy5 (5E10, BioLegend, CA, USA)...",Specific antibody with clone number and vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
5bc35225-17c6-4d59-aad4-b682c517063f,CD271/APC (C401457),,,,,,,PMID:29941005,,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,methods,1.0,"...CD146/PE (P1H12, BD Biosciences), CD271/APC (C401457, BD Biosciences). Unstained cells were used as controls...",Specific antibody with clone number and vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
fd5c6742-afb4-44f4-a3e3-81e24efa5372,anti-Ki-67 (M7240),,,,,,,PMID:29941005,,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,methods,1.0,"...Expression of Ki-67 was evaluated immunohistochemically using mouse monoclonal antibody anti-Ki-67 (1:80; M7240; Dako Corporation, CA, USA)...",Specific antibody with catalog number and vendor information not captured,,AI validation - Sonnet 4.5,0,0,,
0cf86e79-8b6a-456c-89e2-f88a7864516a,S100 antibody,,,,,,,PMID:30055648,,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,methods,1.0,"antibodies against S100 (monoclonal, mouse, 10 μg/mL, Ventana S100-4C4.9) to demonstrate human Schwann cell origin",Antibody with vendor and clone information not captured - need patterns for Ventana antibodies,,AI validation - Sonnet 4.5,0,0,,
0fde971a-26cc-41c7-8899-2d06e27d198d,Ki67 antibody,,,,,,,PMID:30055648,,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,methods,1.0,"anti-Ki67 (monoclonal, mouse, 0.4 μg/mL, Ventana Ki-67-30.9) to evaluate proliferation fraction",Antibody with vendor and clone information not captured,,AI validation - Sonnet 4.5,0,0,,
24d98737-1297-4e09-a0b5-a3ba1ae09d15,CD34 antibody,,,,,,,PMID:30055648,,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,methods,1.0,"anti-CD34 (monoclonal, mouse, 0.8 μg/mL, Ventana QBEnd/10) to demonstrate vessel and stem cell formation",Antibody with vendor and clone information not captured,,AI validation - Sonnet 4.5,0,0,,
17d231a2-1d4b-4133-b104-ce073c97806b,p53 antibody,,,,,,,PMID:30055648,,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,methods,1.0,"anti-p53 (monoclonal, mouse, Ventana Bp-53-11), anti-p16 (monoclonal, mouse, 1 μg/mL, Ventana 725-4713)",Antibody with vendor and clone information not captured,,AI validation - Sonnet 4.5,0,0,,
d7e07a34-2dcc-458d-8a6a-7cbad2b3dd0f,p16 antibody,,,,,,,PMID:30055648,,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,methods,1.0,"anti-p16 (monoclonal, mouse, 1 μg/mL, Ventana 725-4713), anti-vimentin (vimentin, monoclonal, mouse",Antibody with vendor and clone information not captured,,AI validation - Sonnet 4.5,0,0,,
e069df49-b816-437e-b98d-919dc38bc00f,merlin antibody,,,,,,,PMID:30274821,,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,methods,1.0,"Immunoblotting analysis was performed with antibodies specific for merlin (# HPA003097, Sigma-Aldrich; # sc331, Santa Cruz)",Antibody with specific catalog numbers and vendors not detected,,AI validation - Sonnet 4.5,0,0,,
139608bb-28c4-4da8-b52a-45cec1bac680,p53 antibody,,,,,,,PMID:30274821,,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,methods,1.0,"p53 (# P6874, Sigma-Aldrich; # 2524, Cell Signaling)",Antibody with specific catalog numbers and vendors not detected,,AI validation - Sonnet 4.5,0,0,,
11ecee46-fa1f-44cc-afca-c8dc6e7b2bb9,p27 antibody,,,,,,,PMID:30615146,,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,results,0.85,"Each decreased phosphorylated pERK1/2 and cyclin D1, increased p27",Antibody target mentioned without explicit 'antibody' keyword,,AI validation - Sonnet 4.5,0,0,,
e11724cd-9401-4926-9780-8a74c30d97f8,Ki-67 antibody,,,,,,,PMID:30615146,,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,results,0.85,"decreased pERK1/2, cyclin D1, and Ki-67 levels were observed only in PD0325901 and cobimetinib-treated grafts",Antibody target mentioned without explicit 'antibody' keyword,,AI validation - Sonnet 4.5,0,0,,
6ec012ef-8197-484f-9cfd-e7b980e3680b,caspase-3 antibody,,,,,,,PMID:30615146,,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,results,0.85,"increased p27, and induced caspase-3 cleavage in MD-MSCs",Antibody target mentioned without explicit 'antibody' keyword,,AI validation - Sonnet 4.5,0,0,,
a5b8eb23-45f9-4e5e-a6d0-186343a68b1c,KRAS antibody,,,,,,,PMID:31836666,,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,methods,1.0,Western blots...probed with a series of antibodies:...KRAS (Sigma/Novus Biologicals WH0003845M1/H0003845M1),Protein-specific antibody with catalog numbers not detected,,AI validation - Sonnet 4.5,0,0,,
142948fe-3641-46b0-b17f-d6fd100b504e,rabbit anti-GAPDH,,,,,,,PMID:32457840,,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",methods,1.0,"rabbit anti-GAPDH, rabbit anti-Histone 3, rabbit anti-Merlin, mouse anti-p53, mouse anti-Ki67, and rabbit anti-β-catenin, all from Cell Signaling",Antibody name not caught by mining patterns,,AI validation - Sonnet 4.5,0,0,,
b2b4f537-f613-4479-8e19-b6a8350e2a4b,rabbit anti-Merlin,,,,,,,PMID:32457840,,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",methods,1.0,"rabbit anti-GAPDH, rabbit anti-Histone 3, rabbit anti-Merlin, mouse anti-p53, mouse anti-Ki67, and rabbit anti-β-catenin, all from Cell Signaling",Antibody name not caught by mining patterns - particularly relevant as Merlin/NF2 is in the title,,AI validation - Sonnet 4.5,0,0,,
fd7a6f68-ef49-48c1-ae22-bee09ab6ceef,Ki67 antibody,,,,,,,PMID:32948135,,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,methods,1.0,"antigen Ki67, monoclonal mouse anti-human Ki67 antigen, clone MIB1, M7240, DAKO",Antibody with full catalog information not detected - needs pattern for DAKO catalog numbers,,AI validation - Sonnet 4.5,0,0,,
b23bd7e8-9476-407b-818b-941e8db0336b,p53 antibody,,,,,,,PMID:32948135,,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,methods,1.0,"tumor protein p53 (p53, monoclonal mouse anti-human p53 M7001, DAKO)",Antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
ded50ed3-d71b-47d9-a331-cb1c69352ebd,p21 antibody,,,,,,,PMID:32948135,,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,methods,1.0,"p21, monoclonal mouse anti-human p21 WAF1/Cip1 , M7202, DAKO",Antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
5c3fdd81-8c31-4dd7-a18a-12a560504a8f,goat anti-collagen IV,,,,,,,PMID:33078583,,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,methods,1.0,The primary antibodies and dilutions used were goat anti-collagen IV (Millipore AB769; 1:500),Antibody naming pattern with vendor info not captured,,AI validation - Sonnet 4.5,0,0,,
7af67cc8-9dd7-4730-b849-f997bbe53bf8,rabbit anti-laminin,,,,,,,PMID:33078583,,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,methods,1.0,rabbit anti-laminin (Sigma-Aldrich L9393; 1:500),Antibody naming pattern with vendor info not captured,,AI validation - Sonnet 4.5,0,0,,
d15fbf72-8a71-4878-ad82-abf3f8e76ada,rabbit anti-phosphor (s235/236) S6,,,,,,,PMID:33078583,,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,methods,1.0,rabbit anti-phosphor (s235/236) S6 (Cell Signaling Technology 4858),Antibody naming pattern with vendor info not captured,,AI validation - Sonnet 4.5,0,0,,
f1073b90-9eef-4e47-a275-8d205f229acd,ERBB3 antibody,,,,,,,PMID:33273014,,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,methods,1.0,"Antibodies recognizing ERRB3 Y1197, ERBB3, EPHA2 S897, NDRG1 T346, Akt S473, Akt T308, Akt, p70S6K T389",Antibody target names not captured as antibodies,,AI validation - Sonnet 4.5,0,0,,
f8c4ac76-4b44-47ff-974e-467c942e49e1,IGF1R antibody,,,,,,,PMID:33273014,,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,methods,1.0,"IGF1R Y1135/36/IR Y1150/51, IGF1R, FOXO1/3a T24/T32, and FOXO3 were from Cell Signaling",Antibody target names not captured as antibodies,,AI validation - Sonnet 4.5,0,0,,
e22d3fcc-7778-4a2f-9b38-c54621615086,GAPDH antibody,,,,,,,PMID:33273014,,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,methods,1.0,"Other antibodies included EPHA2 (Santa Cruz), secreted form of NRG1 (R&D Systems), NDRG1 (Abcam), and GAPDH (EMD Millipore)",Antibody target names not captured as antibodies,,AI validation - Sonnet 4.5,0,0,,
833cf3b6-b725-496f-8e19-400e2e5b8291,NF2/merlin antibody,,,,,,,PMID:33273014,,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,methods,1.0,Anti-NF2/merlin polyclonal antibody has been previously described,Custom antibody not captured,,AI validation - Sonnet 4.5,0,0,,
2878fe02-3a9f-42ef-af33-d51f2e27d3fb,S100,,,,,,,PMID:33356508,,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,abstract,1.0,"Immunostaining with markers such as S100, β-tubulin III, Foxp3, CD45, Vimentin, and Ki67 confirmed low-grade tumor formation",Antibody marker not recognized in immunostaining context,,AI validation - Sonnet 4.5,0,0,,
f9eab139-76bc-46bb-a8e7-2086885f9ea4,CD45,,,,,,,PMID:33356508,,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,abstract,1.0,"Immunostaining with markers such as S100, β-tubulin III, Foxp3, CD45, Vimentin, and Ki67 confirmed low-grade tumor formation",Antibody marker not recognized in immunostaining context,,AI validation - Sonnet 4.5,0,0,,
100fd1a2-c640-4faa-bb0b-43f10afc7745,Ki67,,,,,,,PMID:33356508,,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,abstract,1.0,"Immunostaining with markers such as S100, β-tubulin III, Foxp3, CD45, Vimentin, and Ki67 confirmed low-grade tumor formation",Antibody marker not recognized in immunostaining context,,AI validation - Sonnet 4.5,0,0,,
262ad7fb-53ae-4db8-8315-3fc84ad0d4ef,GFAP,,,,,,,PMID:33356508,,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,methods,1.0,"labeled overnight at room temperature with the following conjugated primary antibodies: S100-FITC, Vimentin-FTIC, CD45-APC, Ki67-APC, and GFAP-APC.",Additional antibody marker found in detailed methods not captured in abstract,,AI validation - Sonnet 4.5,0,0,,
5903388c-1734-49c0-97df-8ef04312339a,phospho-ERK1/2 antibody (Cell Signaling #9101),,,,,,,PMID:33436083,,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,methods,1.0,"...phospho-p38 (Cell Signaling # 4511), phospho-ERK1/2 (Cell Signaling #9101), and β-Actin (Cell Signaling #3700)...",Specific antibody with catalog number not caught by mining patterns,,AI validation - Sonnet 4.5,0,0,,
c844aa77-dc51-42e6-8971-c6c8ca90a2fb,NGFR antibody,,,,,,,PMID:33574490,,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,methods,1.0,"Cells were incubated with α-tubulin (Invitrogen, 1:1000) and NGFR (Advance Targeting systems, 1:100) antibodies",Antibody with vendor and dilution information,,AI validation - Sonnet 4.5,0,0,,
46d86791-b4ee-4600-a80f-af0ad53c4d72,P-ERK 1/2 antibody,,,,,,,PMID:33574490,,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,methods,1.0,All antibodies used were diluted in 3% non-fat dry milk and include P-ERK 1/2 (Cell Signalling diluted 1:2000),Antibody with vendor and dilution information,,AI validation - Sonnet 4.5,0,0,,
2ac8de55-c156-46c3-864c-5e21c82c1a76,ERK 1/2 antibody,,,,,,,PMID:33574490,,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,methods,1.0,"ERK 1/2 (Millipore diluted 1:1000), P-PKA α/β (Invitrogen diluted 1ug/ml)",Antibody with vendor and dilution information,,AI validation - Sonnet 4.5,0,0,,
f6c791de-f7c1-4220-909c-9d197e41cb74,NF1 c-terminal antibody,,,,,,,PMID:33574490,,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,methods,1.0,"NF1 c-terminal (Bethyl diluted 1:1000), NF1 n-terminal (Santa Cruz diluted 1:500)",Antibody with vendor and dilution information,,AI validation - Sonnet 4.5,0,0,,
a0740390-022d-449e-a5b2-94683ff62bef,NF1 n-terminal antibody,,,,,,,PMID:33574490,,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,methods,1.0,NF1 n-terminal (Santa Cruz diluted 1:500) and α-Tubulin (Sigma Aldrich 1:1000),Antibody with vendor and dilution information,,AI validation - Sonnet 4.5,0,0,,
b1b0cb4e-3e5d-4e58-814d-e023872809c9,NF1 antibody (#D7R7D),,,,,,,PMID:34011935,,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,methods,1.0,"phospho-ERK (#D13.14.4E), MMP1 (#E9S9N), and NF1 (#D7R7D), as well as anti-rabbit IgG HRP-linked antibody were purchased from Cell Signaling Technology",Specific antibody with clone number from Cell Signaling Technology,,AI validation - Sonnet 4.5,0,0,,
5a528412-0fb7-44fe-b3dd-013608f93f27,phospho-MEK1/2 antibody (#41G9),,,,,,,PMID:34011935,,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,methods,1.0,"Antibodies used in western blotting targeting β-actin (#13E5), MEK1/2, Akt, c-Raf, ERK, phospho-MEK1/2 (#41G9)",Phospho-specific antibody with clone number for pathway analysis,,AI validation - Sonnet 4.5,0,0,,
0798d52b-6d66-4bec-b56a-8e609207aca7,phospho-c-Raf antibody (#56A6),,,,,,,PMID:34011935,,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,methods,1.0,"phospho-Akt (#D9E), phospho-c-Raf (#56A6), phospho-ERK (#D13.14.4E), MMP1 (#E9S9N)",Phospho-specific antibody with clone number,,AI validation - Sonnet 4.5,0,0,,
f3c754ee-2064-4dde-84fc-c0b6193967b2,phospho-ERK antibody (#D13.14.4E),,,,,,,PMID:34011935,,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,methods,1.0,"phospho-c-Raf (#56A6), phospho-ERK (#D13.14.4E), MMP1 (#E9S9N), and NF1 (#D7R7D)",Phospho-specific antibody with clone number,,AI validation - Sonnet 4.5,0,0,,
b83d9cac-9e7d-4108-b50e-bc3bf8b42ee9,Aryl hydrocarbon receptor antibody (#H-211),,,,,,,PMID:34011935,,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,methods,1.0,"Antibody for Aryl hydrocarbon receptor (AHR, #H-211) was from Santa Cruz Biotechnology (Dallas, TX, USA)",Specific antibody with clone number from Santa Cruz,,AI validation - Sonnet 4.5,0,0,,
e67f7e05-9246-4157-a8e6-bde900a84074,collagen I antibody (#EPR7785),,,,,,,PMID:34011935,,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,methods,1.0,"that for collagen I (#EPR7785) was from Abcam. For immunohistochemical analysis, anti-collagen antibody",Specific antibody with clone number from Abcam,,AI validation - Sonnet 4.5,0,0,,
d9fbff26-21c7-408f-85e6-6955d4d91b1f,anti-S100 protein antibody,,,,,,,PMID:34011935,,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,methods,1.0,"anti-collagen antibody (Nichirei Biosciences Inc.), anti-MMP1 antibody (Nichirei Biosciences Inc.), anti-S100 protein antibody (Nichirei Biosciences Inc.)",Specific antibody used for immunohistochemical analysis,,AI validation - Sonnet 4.5,0,0,,
48524601-e310-4008-a0c2-656d054afe55,anti-phospho-ERK,,,,,,,PMID:34257279,,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,methods,0.95,"anti-phospho-ERK (mouse, Sigma M8159, 1:2500)",Antibody target name not recognized - includes catalog number,,AI validation - Sonnet 4.5,0,0,,
e050997c-4258-4596-b618-81f568c5e427,ERK antibody,,,,,,,PMID:34428430,,Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.,methods,1.0,"ERK, Cell Signaling Technology, #4696, 1:1000 or Cell Signaling Technology, #4695, 1:1000",Primary antibody with vendor and catalog numbers for Western blot,,AI validation - Sonnet 4.5,0,0,,
7c6a2911-6cd4-49bf-a8e2-dc5451423ac9,GFAP antibody,,,,,,,PMID:34428430,,Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.,methods,1.0,"GFAP, Agilent, #Z0334, 1:2000",Primary antibody with vendor and catalog number for immunohistochemistry,,AI validation - Sonnet 4.5,0,0,,
02f973b0-d1c8-4d75-b15e-164b115ad27a,total ERK antibody,,,,,,,PMID:36730269,,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,methods,1.0,The following antibodies were purchased from Cell signaling Technologies: total ERK (Catalogue # 9102),Antibody with specific catalog number from Cell Signaling Technologies,,AI validation - Sonnet 4.5,0,0,,
8d98eaa7-4cb0-48dc-9952-d96522e5a906,SOX2 antibody,,,,,,,PMID:36730269,,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,methods,1.0,SOX2 (Catalogue # MAB2018) from R&D systems,Antibody with specific catalog number from R&D Systems,,AI validation - Sonnet 4.5,0,0,,
cbfa4689-d8fd-47f6-bdd7-b8149eb4497a,anti-GAPDH antibody,,,,,,,PMID:37446790,,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,methods,1.0,Antibodies against GAPDH (cat. no. 5174S)...were obtained from Cell Signaling Technology,Antibody with catalog number and vendor - clear tool indicator,,AI validation - Sonnet 4.5,0,0,,
f7d28d52-4dc1-4e4c-a280-17d8799c22d4,anti-neurofibromin antibody,,,,,,,PMID:37446790,,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,methods,1.0,Antibody against neurofibromin (cat. no. ab17963) was purchased from Abcam,Antibody with catalog number and vendor,,AI validation - Sonnet 4.5,0,0,,
6fe6fbed-10ef-4bff-b6ca-ed23b6777bc2,anti-p75 NGFR antibody,,,,,,,PMID:37520682,,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,methods,1.0,Schwann cells were isolated from contaminating fibroblasts via p75 NGFR antibody-mediated magnetic cell selection,Antibody target name without 'antibody' keyword in immediate context,,AI validation - Sonnet 4.5,0,0,,
9a802926-a9a7-441a-a179-d369320eeeda,SOX10 antibody,,,,,,,PMID:37770931,,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",methods,1.0,"SOX10 (Roche (Catalog#: 760-4968), pre-diluted kit)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
b96cc320-c69e-4068-a637-14e7d528620d,S100 antibody,,,,,,,PMID:37817770,,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,abstract,0.95,"...exhibited classic diffuse-type histologic morphology and expected patterns of S100, SOX10, GFAP, and CD34 immunohistochemistry...",Antibody used for immunohistochemistry but mentioned without 'antibody' keyword,,AI validation - Sonnet 4.5,0,0,,
b6a301a3-d12d-4b05-853b-7c86b3f81514,SOX10 antibody,,,,,,,PMID:37817770,,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,abstract,0.95,"...exhibited classic diffuse-type histologic morphology and expected patterns of S100, SOX10, GFAP, and CD34 immunohistochemistry...",Antibody used for immunohistochemistry but mentioned without 'antibody' keyword,,AI validation - Sonnet 4.5,0,0,,
b181443c-8bc7-478b-a487-fd8857ba1d4b,GFAP antibody,,,,,,,PMID:37817770,,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,abstract,0.95,"...exhibited classic diffuse-type histologic morphology and expected patterns of S100, SOX10, GFAP, and CD34 immunohistochemistry...",Antibody used for immunohistochemistry but mentioned without 'antibody' keyword,,AI validation - Sonnet 4.5,0,0,,
1b680885-20f2-4fd8-af76-316f3562908f,CD34 antibody,,,,,,,PMID:37817770,,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,abstract,0.95,"...exhibited classic diffuse-type histologic morphology and expected patterns of S100, SOX10, GFAP, and CD34 immunohistochemistry...",Antibody used for immunohistochemistry but mentioned without 'antibody' keyword,,AI validation - Sonnet 4.5,0,0,,
a7a2bce7-bf1a-48ae-9b42-459836171731,anti-IBA1 antibody,,,,,,,PMID:37990867,,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,methods,0.95,Cells were next stained with anti-IBA1 antibody (Table S1) in TBS containing 5% donkey serum overnight,Primary antibody with clear 'anti-' prefix not identified by antibody mining patterns,,AI validation - Sonnet 4.5,0,0,,
e2917737-9b7d-480b-a4f2-86add48fd451,pan-RAS antibody,,,,,,,PMID:38201517,,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,methods,1.0,"N-, K-, and H-RAS were detected with a 1:100 dilution of murine monoclonal pan-RAS antibody (BD Biosciences, San Diego, CA, USA, product #610002).",Antibody with catalog number should have been caught,,AI validation - Sonnet 4.5,0,0,,
b2e59380-7553-4154-965c-31b0a76efac6,N-RAS antibody,,,,,,,PMID:38201517,,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,methods,1.0,"N-RAS was detected with a 1:400 dilution of a rabbit polyclonal N-RAS antibody (Santa Cruz, CA, USA, product #sc-519).",Specific antibody with catalog number not recognized,,AI validation - Sonnet 4.5,0,0,,
0344213e-58ca-49c0-ab8e-47dfcd0a2e03,GAPDH antibody,,,,,,,PMID:38201517,,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,methods,1.0,"GAPDH was detected with a 1:1000 dilution of rabbit polyclonal antibody to GAPDH (Cell Signaling, Boston, MA, USA, product #2118).",Loading control antibody with catalog number missed,,AI validation - Sonnet 4.5,0,0,,
6dc4d6bb-9742-48a7-8dc7-272605572b7c,neurofibromin antibody (Bethyl A300-140A),,,,,,,PMID:38216123,,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,methods,1.0,"Immunoblotting was carried out using antibodies against neurofibromin – Bethyl (Bethyl, Cat# A300-140A, primary 1:500, secondary 1:2000)",Antibody with specific catalog number should have been detected,,AI validation - Sonnet 4.5,0,0,,
a73a5473-d2f9-403f-b68e-056c41525cac,neurofibromin antibody H12,,,,,,,PMID:38216123,,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,methods,1.0,"H12 (Santa Cruz Biotechnology, Cat# sc-376886, primary 1:500, secondary 1:2000)",Antibody with specific catalog number should have been detected,,AI validation - Sonnet 4.5,0,0,,
02d34a5d-dfab-4127-86e7-1bb1c87a4e7e,ERK antibody,,,,,,,PMID:38216123,,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,methods,1.0,"ERK (Cell Signaling Technology, Cat#4695S)",Antibody with catalog number should have been detected,,AI validation - Sonnet 4.5,0,0,,
530d100c-89a5-4d21-8b0a-51293e25b6de,Ki67,,,,,,,PMID:38387803,,Development of a vestibular schwannoma tumor slice model for pharmacological testing.,abstract,0.9,Treatment responses were assessed using CC3 as an apoptosis marker and Ki67 as a proliferation marker,Ki67 is a standard proliferation marker antibody but may not be recognized by current patterns,,AI validation - Sonnet 4.5,0,0,,
892a745a-b1f0-4095-b956-f0f98b3bd0af,anti-neurofibromin antibody,,,,,,,PMID:38481529,,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,methods,1.0,"incubated overnight with the primary anti-neurofibromin antibody (abcam, ab17963, 1/1000)",Primary antibody with catalog number for Western blot,,AI validation - Sonnet 4.5,0,0,,
f52af9ee-55fb-4692-94bb-8892fb51668d,S100 antibody,,,,,,,PMID:38900740,,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,methods,1.0,"The following primary antibodies were used in the immunohistochemistry studies: S100 (Agilent Technologies, GA-50461-2)",Antibody name without 'antibody' suffix not captured,,AI validation - Sonnet 4.5,0,0,,
10d930a9-c62c-4adc-a4ea-903dfb2134a7,Nf1 antibody,,,,,,,PMID:38900740,,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,methods,1.0,"Nf1 (Santa Cruz, sc-376886)",Gene name used as antibody target not distinguished from disease reference,,AI validation - Sonnet 4.5,0,0,,
60850796-c0bb-4866-ac10-778fdce64473,p53 antibody,,,,,,,PMID:38900740,,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,methods,1.0,"p53 (Santa Cruz, sc-126)",Gene name used as antibody target not captured,,AI validation - Sonnet 4.5,0,0,,
a03b8aa1-1e17-4927-8f82-5e743b7a1a79,Iba1 antibody,,,,,,,PMID:38900740,,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,methods,1.0,"Iba1 (Fujifilm, 019-19741)",Antibody name without 'antibody' suffix not captured,,AI validation - Sonnet 4.5,0,0,,
18290f76-f702-4a49-8a50-acf00e01fb4d,anti-cleaved caspase 3 (Asp175),,,,,,,PMID:39016685,,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,methods,1.0,"anti-cleaved caspase 3 (Asp175) rabbit polyclonal (1:200; cat. no 9661, Cell Signaling Technology)",Antibody with epitope specification not detected,,AI validation - Sonnet 4.5,0,0,,
92c82e6c-fef3-4bfb-a677-00d481d44950,anti-NF1 (D7R7D),,,,,,,PMID:39016685,,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,methods,1.0,"anti-NF1 (D7R7D) rabbit monoclonal (cat. no 14623, Cell Signaling Technology, 1:1000, overnight at 4°C)",NF1 antibody with clone name not detected,,AI validation - Sonnet 4.5,0,0,,
db8a9c88-3465-4e6b-be42-0da5e78c8117,anti-PARP (46D11),,,,,,,PMID:39016685,,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,methods,1.0,"anti-PARP (46D11) rabbit monoclonal (cat. no 9532, Cell Signaling Technology, 1:5000, overnight at 4°C)",Antibody with clone name not detected,,AI validation - Sonnet 4.5,0,0,,
e336c9c4-bb24-4c7a-bdcd-8065f46ca29e,anti-merlin antibody,,,,,,,PMID:39415595,,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,methods,1.0,"Subsequently, the blot was incubated with a 1:1000 dilution of anti-merlin antibody overnight at 4°C.",Antibody name pattern not captured,,AI validation - Sonnet 4.5,0,0,,
0a51517e-5830-4265-aafc-6d7ad8571c00,anti-Sox10 antibody,,,,,,,PMID:39415595,,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,methods,1.0,Anti-Sox10 antibody staining on HCR-processed sections was performed according to Kamenev et al. (2021).,Antibody name pattern not captured,,AI validation - Sonnet 4.5,0,0,,
09a88f11-8d49-4df4-a8c6-438f4e1230e8,neurofibromin antibody,,,,,,,PMID:39890807,,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,methods,1.0,probed overnight at 4°C with either the neurofibromin antibody (Cell Signaling Technologies Cat. #: 14623 S),Antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
a57659eb-2db8-467d-85e6-c1d11e5194fa,CONFIRM anti-Ki67 (clone 30-9),,,,,,,PMID:40394150,,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,methods,0.95,...12-min incubation with the CONFIRM anti-Ki67 (clone 30-9) rabbit monoclonal primary antibody (Roche)...,Specific antibody with clone information and vendor for immunohistochemistry,,AI validation - Sonnet 4.5,0,0,,
7a15c7fd-96a5-4411-8805-9c08b39d50d7,total ERK antibody,,,,,,,PMID:40587782,,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",methods,1.0,"total ERK (Cell Signaling Technologies, #4695, 1:1,000 dilution)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
003b5560-2ba5-492b-ab71-ffd56912b934,pMEK antibody,,,,,,,PMID:40587782,,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",methods,1.0,"pMEK (Cell Signaling Technologies, #9121, 1:1,000 dilution)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
a5374700-cbb5-472d-ace3-dcf57484ff5c,total MEK antibody,,,,,,,PMID:40587782,,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",methods,1.0,"total MEK (Cell Signaling Technologies, #8727, 1:1,000 dilution)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
c01943e0-b015-4255-bbc0-4489d2f1f25d,neurofibromin antibody,,,,,,,PMID:40587782,,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",methods,1.0,"neurofibromin (Millipore, #3668175, 1:1000 dilution)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
e3599cc8-48b3-4665-aba6-03cf58a8c921,SOS2 antibody,,,,,,,PMID:40587782,,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",methods,1.0,"SOS2 (Santa Cruz, sc-393667)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
49ca0746-4696-403f-8a8e-5ed8e722d0f4,neurofibromin/NF1 antibody,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,1.0,"neurofibromin/NF1 (sc-67, sc-376886, Santa Cruz Biotechnology and ab238142, Abcam)",Antibody with multiple catalog numbers not recognized,,AI validation - Sonnet 4.5,0,0,,
83cd7c2c-8975-4272-b745-47bb9b0acfaa,ERK1/2 antibody,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,1.0,"ERK1/2 (9102, Cell Signaling Technology)",Cell Signaling Technology antibody not recognized,,AI validation - Sonnet 4.5,0,0,,
19f1923f-dd8b-4dd8-8fde-2a65f690eebd,anti-pERK Thr202/Tyr204 antibody,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,1.0,"anti-pERK Thr202/Tyr204 (4377, Cell Signaling Technology)",Phospho-specific antibody not recognized,,AI validation - Sonnet 4.5,0,0,,
3eeb8a64-0312-4380-bf5c-3ad288b02087,GAPDH antibody,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,1.0,"GAPDH (2118, Cell Signaling Technology)",Loading control antibody not recognized,,AI validation - Sonnet 4.5,0,0,,
dae6a544-09e1-4e9c-b3d9-198faaccfa5f,S100 mouse monoclonal primary antibody,,,,,,,PMID:41001593,,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,methods,1.0,"S100 mouse monoclonal primary antibody (Cell Signaling Technology, Danvers, USA) diluted 1:1000","Clear antibody mention with vendor, should be caught by antibody patterns",,AI validation - Sonnet 4.5,0,0,,
f1f105e2-6d29-4fd1-a6b7-8856dd889532,anti-NF1 antibody,,,,,,,PMID:41022755,,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,methods,0.98,Rabbit anti-NF1 antibody (A300-140A) was purchased from Bethyl Laboratories,Antibody target name not caught by antibody mining patterns,,AI validation - Sonnet 4.5,0,0,,
62e74d12-df11-439f-bf3c-69f739c18ed1,anti-phospho-ERK1/2 antibody,,,,,,,PMID:41022755,,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,methods,0.98,The rabbit anti-phospho-ERK1/2 (p44/42 MAPK) (Thr202/Tyr204) antibody (#9101),Phospho-specific antibody not caught by antibody mining patterns,,AI validation - Sonnet 4.5,0,0,,
6544a482-0987-44e0-9cd6-43c468bfef2b,neurofibromin 1 (D7R7D) rabbit mAb 14623,,,,,,,PMID:41036607,,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,methods,1.0,Primary and secondary antibodies used were from Cell Signaling Technology: neurofibromin 1 (D7R7D) rabbit mAb 14623 (RRID: AB_2798543),Primary antibody with clone name and RRID identifier,,AI validation - Sonnet 4.5,0,0,,
8acd5624-41c5-4bc7-8023-839d6f35c621,anti-CD33 APC,,,,,,,PMID:41149489,,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,methods,1.0,"...anti-HLA-DR Percp-cy5.5 (eBioscience, 0.015 μg/test, San Diego, CA, USA), anti-CD33 APC (eBioscience, 0.125 μg/test)...",Specific antibody with vendor information - clear research tool,,AI validation - Sonnet 4.5,0,0,,
f7e5edba-fc4e-4b9d-a3b3-4f52e3df1a63,CD81 antibody,,,,,,,PMID:41149489,,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,methods,1.0,"...CD9 (Proteintech, 60232-1-Ig, Wuhan, China), CD81 (Proteintech, 66866-1-Ig)...",Primary antibody with specific catalog number and vendor - clear research tool,,AI validation - Sonnet 4.5,0,0,,
747c79a4-f025-4c6d-a724-77497bcbdc14,ERK antibody,,,,,,,PMID:41149489,,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,methods,1.0,"...p-AKT (CST, #4051S), ERK (CST, #4695)...",Primary antibody with specific catalog number and vendor - clear research tool,,AI validation - Sonnet 4.5,0,0,,
e89d885e-abaf-4768-a016-b4b8bcf321f2,p-ERK antibody,,,,,,,PMID:41149489,,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,methods,1.0,"...ERK (CST, #4695), p-ERK (CST, #9101S)...",Primary antibody with specific catalog number and vendor - clear research tool,,AI validation - Sonnet 4.5,0,0,,
f9c41381-dd58-4598-a663-1010eba4f2d7,Anti-CD31,,,,,,,PMID:41444363,,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,methods,1.0,"Immunohistology analysis of 10 micron dorsal root ganglia cryosections was performed using Anti-CD31 (Abcam, ab7388) for vasculature",Specific antibody with catalog number and vendor - clear research tool,,AI validation - Sonnet 4.5,0,0,,
77758a5f-1374-4a7f-afdc-ae6eae68c87b,Anti-S100B,,,,,,,PMID:41444363,,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,methods,1.0,"Anti-S100B (Atlas Antibodies, HPA015768-100UL) antibodies for S100B protein and DAPI for nuclei",Specific antibody with catalog number and vendor - clear research tool,,AI validation - Sonnet 4.5,0,0,,
bbee7d96-fb0c-4e28-a466-09e07d37dbc7,N-Terminal NF1 antibody,,,,,,,PMID:41564118,,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,methods,1.0,...Primary antibodies included N-Terminal NF1 (Cell Signaling cat# D7R7D 1:1000)...,Antibody with catalog number not captured by antibody mining patterns,,AI validation - Sonnet 4.5,0,0,,
208e70f2-1b90-43e3-90ed-ebc5204a5906,p-ERK antibody,,,,,,,PMID:41564118,,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,methods,1.0,...p-ERK (Cell Signaling cat# 9101 1:1000)...,Antibody with catalog number not captured by antibody mining patterns,,AI validation - Sonnet 4.5,0,0,,
2335a760-06d6-4039-a517-cacd1e3a2ebe,total ERK antibody,,,,,,,PMID:41564118,,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,methods,1.0,...total ERK (Cell Signaling cat# 9102 1:1000)...,Antibody with catalog number not captured by antibody mining patterns,,AI validation - Sonnet 4.5,0,0,,
b440cd14-14a8-4748-a996-8b909d9fac33,MET antibody,,,,,,,PMID:41616055,,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,methods,1.0,"MET: #ab216574 or #ab51067, Abcam (1:100); SOX10: #ab180862, Abcam (1:100)",Antibody with multiple catalog numbers not recognized,,AI validation - Sonnet 4.5,0,0,,
49691ddc-dd9d-4dba-bd28-1e52ed6dab08,SOX10 antibody,,,,,,,PMID:41616055,,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,methods,1.0,"SOX10: #ab180862, Abcam (1:100); NLRP3: #CAB12694, Assay Genie (1:1000 dilution)",Antibody with vendor and dilution information not detected,,AI validation - Sonnet 4.5,0,0,,
ed19396b-0bf7-42f5-930d-d493ea26369d,CD68 antibody,,,,,,,PMID:41616055,,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,methods,1.0,"CD68, Cell Signaling Technology (1:100)]. Incubation with secondary antibody was performed",Antibody with vendor information not detected,,AI validation - Sonnet 4.5,0,0,,
2f36b4e6-8efe-4b61-a3d2-fd11633088f1,monoclonal antibodies to amino- and carboxyl-terminal synthetic NF2 peptides,,,,,,,PMID:7485397,,Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.,abstract,0.95,Using monoclonal antibodies to amino- and carboxyl-terminal synthetic NF2 peptides we demonstrate the co-localization of the NF2 protein with elements of the cytoskeleton,Mining patterns likely don't capture the full descriptive phrase 'monoclonal antibodies to amino- and carboxyl-terminal synthetic NF2 peptides',,AI validation - Sonnet 4.5,0,0,,
0d657c05-b59b-4cf3-8c2b-af78869b51cd,NF1 antibody (Santa Cruz; sc-67),,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,"The following primary antibodies were used in the immunohistochemistry studies: K1 (BioLegend, 905601, 1:100), NF1 (Santa Cruz; sc-67, 1:100), H3K27Me3 (Cell Signaling, 9733S, 1:500), and S100 (DAKO, Z0311, 1:5000).",Clear antibody mention with vendor and catalog number in methods section,,AI validation - Sonnet 4.5,0,0,,
8ee2453a-7c90-486b-b49e-3ecaf09420f9,"H3K27Me3 antibody (Cell Signaling, 9733S)",,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,"The following primary antibodies were used in the immunohistochemistry studies: K1 (BioLegend, 905601, 1:100), NF1 (Santa Cruz; sc-67, 1:100), H3K27Me3 (Cell Signaling, 9733S, 1:500), and S100 (DAKO, Z0311, 1:5000).",Clear antibody mention with vendor and catalog number in methods section,,AI validation - Sonnet 4.5,0,0,,
48d3029a-4540-4156-81a9-a2cb4674869c,"S100 antibody (DAKO, Z0311)",,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,"The following primary antibodies were used in the immunohistochemistry studies: K1 (BioLegend, 905601, 1:100), NF1 (Santa Cruz; sc-67, 1:100), H3K27Me3 (Cell Signaling, 9733S, 1:500), and S100 (DAKO, Z0311, 1:5000).",Clear antibody mention with vendor and catalog number in methods section,,AI validation - Sonnet 4.5,0,0,,
8d98576d-463a-43c5-b898-555bffebc640,NF1 antibody (Santa Cruz; H-12),,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,"Purified cells were lyzed and analyzed by immunoblot analysis with the following antibodies: NF1 (Santa Cruz; H-12, 1:100); K1 (BioLegend, 905601, 1:1000); LUMICAN (Santa Cruz; sc-166871, 1:200).",Clear antibody mention with vendor and clone information for Western blot,,AI validation - Sonnet 4.5,0,0,,
89f8419c-f69b-4d16-b14c-59a93bc90893,anti-CD3 antibody (eBioscience; 16-0031-86),,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,Purified CD3+ T cells (2×105/well) were cultured for 2 days in 96-well plates (in triplicate) precoated with indicated doses of anti-CD3 Ab (eBioscience; cat. no. 16-0031-86),Functional antibody with vendor and catalog number,,AI validation - Sonnet 4.5,0,0,,
3f5e706b-3b70-4a1b-a37d-3ace4b2b33dd,CD4 antibody (eBioscience; 17-0042-83),,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,"Ab directed at T cell (CD4 [eBioscience; cat. no. 17-0042-83; 1:100], CD8 [Lifetech; cat. no. A15836; 1:100], FoxP3 [eBioscience; cat. no. 12-57773-80; 1:100])",Flow cytometry antibody with vendor and catalog number,,AI validation - Sonnet 4.5,0,0,,
fd067636-45ae-485d-8429-77bca80d59ed,CD8 antibody (Lifetech; A15836),,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,"Ab directed at T cell (CD4 [eBioscience; cat. no. 17-0042-83; 1:100], CD8 [Lifetech; cat. no. A15836; 1:100], FoxP3 [eBioscience; cat. no. 12-57773-80; 1:100])",Flow cytometry antibody with vendor and catalog number,,AI validation - Sonnet 4.5,0,0,,
bf789b46-a6b7-4e47-a056-c73847516e21,CD45 antibody (eBioscience; 25-0451-82),,,,,,,PMID:8176268,,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,methods,1.0,"B-cell (B220 [eBioscience; cat. no. 11-0452-85; 1:100]), and pan hematopoietic (CD45 [eBioscience; cat. no. 25-0451-82; 1:100)",Flow cytometry antibody with vendor and catalog number,,AI validation - Sonnet 4.5,0,0,,
f2e4a48f-beac-4ba0-b2dc-3a926b9b4a22,MET antibody,,,,,,,PMID:28775147,,Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.,methods,1.0,"MET: #ab216574 or #ab51067, Abcam (1:100)",Antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
5afff217-9e7b-438d-a4d2-5257ce991a2b,SOX10 antibody,,,,,,,PMID:28775147,,Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.,methods,1.0,"SOX10: #ab180862, Abcam (1:100)",Antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
bd59d43c-0846-460a-a693-2062cdc9c465,CD68 antibody,,,,,,,PMID:28775147,,Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.,methods,0.9,"CD68, Cell Signaling Technology (1:100)",Antibody without catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
50c272e8-5d47-47f4-a47e-d6f331b3b9a6,total ERK antibody,,,,,,,PMID:28775147,,Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.,methods,1.0,"total ERK (#9102, Cell Signaling Technology)",Antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
f58727f6-a52f-4f32-8608-22502b0ba67f,cleaved caspase 3 antibody,,,,,,,PMID:28775147,,Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.,methods,1.0,"cleaved caspase 3 (#9664S, Cell Signaling Technology)",Antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
3816fc5a-84b7-4690-9529-aac241ab7bbe,GAPDH antibody,,,,,,,PMID:28775147,,Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.,methods,1.0,"glyceraldehyde-3-phosphate dehydrogenase (GAPDH; #365062, Santa Cruz Biotechnology)",Antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
ed46907b-3793-47a8-971e-db984682e9af,NF1 antibody,,,,,,,PMID:30479396,,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,methods,1.0,"NF1 (Santa Cruz; sc-67, 1:100)",Antibody with vendor and catalog info not captured,,AI validation - Sonnet 4.5,0,0,,
070296a5-e75f-4078-9d7b-2e4a5bb67e76,H3K27Me3 antibody,,,,,,,PMID:30479396,,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,methods,1.0,"H3K27Me3 (Cell Signaling, 9733 S, 1:500)",Histone modification antibody not detected,,AI validation - Sonnet 4.5,0,0,,
e2c5a849-3578-4685-add5-dd5b1491583e,S100 antibody,,,,,,,PMID:30479396,,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,methods,1.0,"S100 (DAKO, Z0311, 1:5000)",Protein marker antibody not captured,,AI validation - Sonnet 4.5,0,0,,
372f66cc-0674-4da4-a790-7029cf3041a9,anti-CD3 antibody,,,,,,,PMID:30479396,,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,methods,1.0,precoated with indicated doses of anti-CD3 Ab (eBioscience; cat. no. 16-0031-86),Flow cytometry/functional antibody not captured,,AI validation - Sonnet 4.5,0,0,,
6018f0c0-bdd3-4710-bf55-b58c6572c10d,CD4 antibody,,,,,,,PMID:30479396,,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,methods,1.0,CD4 [eBioscience; cat. no. 17-0042-83; 1:100],T cell marker antibody not detected,,AI validation - Sonnet 4.5,0,0,,
a4549753-957d-470e-b37c-50d49501ac89,CD8 antibody,,,,,,,PMID:30479396,,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,methods,1.0,CD8 [Lifetech; cat. no. A15836; 1:100],T cell marker antibody not captured,,AI validation - Sonnet 4.5,0,0,,
1886e3ee-f193-4d06-8ca0-11c12e945dce,CD45 antibody,,,,,,,PMID:30479396,,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,methods,1.0,pan hematopoietic (CD45 [eBioscience; cat. no. 25-0451-82; 1:100),Pan-hematopoietic marker antibody not detected,,AI validation - Sonnet 4.5,0,0,,
db5dd3d5-b22f-4d30-af80-eb45dc63e541,H3K27me3 antibody,,,,,,,PMID:32642734,,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1,methods,1.0,"Immunohistochemistry for histone 3 lysine trimethylation (H3K27 me3) was performed using rabbit monoclonal antibodies (C36B11, 1:50 dilution; Cell Signaling Technology)",Specific antibody with clone and catalog info not captured,,AI validation - Sonnet 4.5,0,0,,
51e77411-8651-4235-9afe-ed73e491d56c,Cleaved-caspase 3 antibody,,,,,,,PMID:32642734,,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1,methods,1.0,"Immunohistochemical staining for Cleaved-caspase 3 at 1:500 (Cell Signaling Technology, Danvers, MA)",Specific antibody with dilution and vendor not captured,,AI validation - Sonnet 4.5,0,0,,
97dc2e20-8913-434e-9321-a9894e273e1d,Ki67 antibody,,,,,,,PMID:32642734,,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1,methods,1.0,prediluted Ki67 (790-4286; Ventana),Specific antibody with catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
20c73dcc-fbf2-4292-8a85-8133b456524f,S100B antibody,,,,,,,PMID:34237737,,"Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis type 1.",methods,0.9,The successful dissection of the cNF tissue from the overlying skin was confirmed by the 2.21-fold expression of the Schwann cell marker S100B in cNFs compared to skin,Antibody mentioned as Schwann cell marker but not explicitly stated as antibody in methods,,AI validation - Sonnet 4.5,0,0,,
932eb232-49a6-4ccd-9af3-06503dfadb5e,CD117 antibody,,,,,,,PMID:34237737,,"Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis type 1.",abstract,0.95,"The tumors were immunolabeled for the mast cell markers CD117, tryptase, and chymase",Immunolabeling markers mentioned but not captured as antibodies,,AI validation - Sonnet 4.5,0,0,,
f0c37c8c-e9e2-480e-add1-21c3fbe046cd,CONFIRM anti-Ki67 (clone 30-9) rabbit monoclonal primary antibody,,,,,,,PMID:34237737,,"Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis type 1.",methods,1.0,followed by a 12-min incubation with the CONFIRM anti-Ki67 (clone 30-9) rabbit monoclonal primary antibody (Roche),Specific antibody with clone information and vendor not captured,,AI validation - Sonnet 4.5,0,0,,
5625fb41-0315-4b25-89cd-70bdf76efdf8,Phospho-p44/42 ERK1/2 antibody,,,,,,,PMID:33978635,,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,methods,1.0,Primary antibodies against Phospho-p44/42 ERK1/2 (p-ERK) (Cell Signaling Technologies #4370S) and p44/42 ERK1/2 (ERK) (Cell Signaling Technologies #4695S) were used at 1:100 dilution,Specific antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
91c08478-b28a-4e2f-8080-81d3eb50bbbf,p44/42 ERK1/2 antibody,,,,,,,PMID:33978635,,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,methods,1.0,Primary antibodies against Phospho-p44/42 ERK1/2 (p-ERK) (Cell Signaling Technologies #4370S) and p44/42 ERK1/2 (ERK) (Cell Signaling Technologies #4695S) were used at 1:100 dilution,Total ERK antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
1ed3439e-abd6-4600-9f70-7d446037f959,ATRX antibody,,,,,,,PMID:31462295,,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,methods,1.0,"Immunohistochemical studies were systematically performed in most cases using an ATRX antibody (Rabbit polyclonal, 1:200 dilution, catalog# HPA001906 Sigma-Aldrich)",Clear antibody mention with catalog number and vendor - should have been caught by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
fbf8a089-dc5d-4b1d-adb9-64a18a67924a,DAXX antibody,,,,,,,PMID:31462295,,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,methods,1.0,"Immunohistochemistry for DAXX (Rabbit polyclonal, 1:100 dilution, catalog# HPA008736, Atlas Antibodies) was performed manually",Clear antibody mention with catalog number and vendor - should have been caught by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
cdcfe9b3-78a0-46f3-bdfb-bd41a9337383,H3K27me3 antibody,,,,,,,PMID:31462295,,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,methods,1.0,"Immunohistochemistry for H3K27me3 was performed manually in whole tissue sections using a mouse monoclonal antibody (Abcam, Cat# ab6002, Cambridge, MA) at 1:1600 dilution",Clear antibody mention with catalog number and vendor - should have been caught by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
dea80e10-32f6-4a74-a668-c189ec8d81cd,ATRX antibody,,,,,,,PMID:29796169,,Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.,methods,0.98,"Immunohistochemical stain for ATRX (Sigma, HPA001906, 1:300, rabbit polyclonal) was performed with appropriate positive and negative controls.","Specific antibody with vendor (Sigma), catalog number (HPA001906), dilution (1:300), and type (rabbit polyclonal) clearly described in methods section",,AI validation - Sonnet 4.5,0,0,,
2be16322-796c-4757-92fe-fb1f64f93d1b,YAP antibody (#14074; CST),,,,,,,PMID:36148553,,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma,methods,1.0,YAP (1:100; #14074; CST),Antibody with catalog number and vendor not detected,,AI validation - Sonnet 4.5,0,0,,
bc8673b2-dd5d-4b9f-a803-7591869b8202,TAZ antibody (sc-48805; Santa Cruz),,,,,,,PMID:36148553,,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma,methods,1.0,TAZ (1:100; sc-48805; Santa Cruz),Antibody with catalog number and vendor not detected,,AI validation - Sonnet 4.5,0,0,,
fd0d5eba-b5d6-4ca7-891f-e4417b31a8f3,Ki67 antibody (ab15580; Abcam),,,,,,,PMID:36148553,,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma,methods,1.0,Ki67 (1:100; ab15580; Abcam),Antibody with catalog number and vendor not detected,,AI validation - Sonnet 4.5,0,0,,
e782bd6d-5212-444f-8cc5-9ea7c594d01a,GAPDH antibody (AB2302; Merck),,,,,,,PMID:36148553,,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma,methods,1.0,GAPDH (1:5000; AB2302; Merck),Loading control antibody not detected,,AI validation - Sonnet 4.5,0,0,,
b7c74c62-355e-4d08-914a-da05be1da6b4,S100 antibody (GA504; Dako),,,,,,,PMID:36148553,,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma,methods,1.0,S100 (pre-diluted; GA504; Dako),Antibody with catalog number and vendor not detected,,AI validation - Sonnet 4.5,0,0,,
bf318d84-e17c-459a-8bf5-d73d7184fe18,ERK1/2 antibody,,,,,,,PMID:35945271,,Functional restoration of mouse Nf1 nonsense alleles in differentiated cultured neurons,methods,1.0,"...incubated with primary antibodies against ERK1/2 (Cell Signaling Technology), phospho-ERK1/2 (Cell Signaling Technology)...",Antibody target name without 'antibody' keyword not caught,,AI validation - Sonnet 4.5,0,0,,
9434d04f-c054-40f3-b866-bb01906a1382,phospho-ERK1/2 antibody,,,,,,,PMID:35945271,,Functional restoration of mouse Nf1 nonsense alleles in differentiated cultured neurons,methods,1.0,"...primary antibodies against ERK1/2 (Cell Signaling Technology), phospho-ERK1/2 (Cell Signaling Technology), Neurofibromin (Novus Biologicals)...",Phospho-specific antibody name not recognized,,AI validation - Sonnet 4.5,0,0,,
7536b9ef-6d13-471b-8b2c-b6605a8ee526,Neurofibromin antibody,,,,,,,PMID:35945271,,Functional restoration of mouse Nf1 nonsense alleles in differentiated cultured neurons,methods,1.0,"...phospho-ERK1/2 (Cell Signaling Technology), Neurofibromin (Novus Biologicals), AMPD3 (Novus Biologicals)...",Protein target name without explicit 'antibody' term,,AI validation - Sonnet 4.5,0,0,,
17ab3787-e4c1-4aa4-a827-c9fa0cca030d,GAPDH antibody,,,,,,,PMID:35945271,,Functional restoration of mouse Nf1 nonsense alleles in differentiated cultured neurons,methods,1.0,"...β-actin (Santa Cruz Biotechnology), and GAPDH (Santa Cruz Biotechnology). Secondary antibodies used were goat anti-rabbit...",Common loading control antibody missed,,AI validation - Sonnet 4.5,0,0,,
aa8dee85-e4fd-4951-ade6-cbea2df5131e,N-Terminal NF1 antibody,,,,,,,PMID:34694046,,Analysis of patient-specific NF1 variants leads to functional insights for Ras signaling that can impact personalized medicine,methods,1.0,Primary antibodies included N-Terminal NF1 (Cell Signaling cat# D7R7D 1:1000),Antibody with catalog number not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
212d3ec8-910f-45bf-a900-adaa77717a32,p-ERK antibody,,,,,,,PMID:34694046,,Analysis of patient-specific NF1 variants leads to functional insights for Ras signaling that can impact personalized medicine,methods,1.0,p-ERK (Cell Signaling cat# 9101 1:1000),Antibody with catalog number not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
f5334444-5725-4775-819e-9f9248da603c,total ERK antibody,,,,,,,PMID:34694046,,Analysis of patient-specific NF1 variants leads to functional insights for Ras signaling that can impact personalized medicine,methods,1.0,total ERK (Cell Signaling cat# 9102 1:1000),Antibody with catalog number not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
d6d74da2-001f-4ee7-9fb8-39fa37ff2301,CD3 antibody,,,,,,,PMID:37949359,,Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1,abstract,0.8,...Most samples displayed intratumoral or peritumoral aggregations of CD3-positive cells...,"Abstract mentions CD3-positive cells indicating immunolabeling with CD3 antibody, but specific antibody not explicitly named",,AI validation - Sonnet 4.5,0,0,,
a8b29495-a9b2-4642-b93f-5484d64b93a2,CD163 antibody,,,,,,,PMID:37949359,,Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1,abstract,0.8,"...CD163-positive cells, suggestive of M2 macrophages, were abundant in cNFs...","Abstract mentions CD163-positive cells indicating immunolabeling with CD163 antibody, but specific antibody not explicitly named",,AI validation - Sonnet 4.5,0,0,,
02d1c5d2-1c3f-4bdb-b70b-b2e4a0deeef3,"p75 antibody (Ab3125, Abcam)",,,,,,,PMID:38175707,,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas,methods,1.0,"incubated for 30 minutes on ice with unconjugated primary antibody p75 (1:1,000, Ab3125, Abcam)",Antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
289ce710-8913-403a-b2b4-de61a4b19d19,"S100B antibody (Z0311, Dako)",,,,,,,PMID:38175707,,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas,methods,1.0,"incubated with primary antibodies, p75 (1:100, Ab3125, Abcam), S100B (1:1,000, Z0311, Dako)",Antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
62753598-0010-4a22-9540-3c1a91ab3a7b,"MPZ antibody (Ab183868, Abcam)",,,,,,,PMID:38175707,,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas,methods,1.0,"and MPZ (1:100, Ab183868, Abcam), overnight at 4°C",Antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
cfc2e084-3eed-4da6-94ca-15affa73168f,SOX10 antibody,,,,,,,PMID:38216587,,Epigenetic reprogramming shapes the cellular landscape of schwannoma,methods,1.0,"labeled with primary antibodies including SOX10 to mark schwannoma cells (API 3099, Biocare)",Antibody with catalog number not caught,,AI validation - Sonnet 4.5,0,0,,
16df9e16-dee1-4ac9-bb4f-630fd2d9b6e2,CD3 antibody,,,,,,,PMID:38216587,,Epigenetic reprogramming shapes the cellular landscape of schwannoma,methods,1.0,"labeled with CD3 (A0452, Agilent Technologies, Santa Clara, CA; labeling validated by over-expression)",Antibody with catalog number not caught,,AI validation - Sonnet 4.5,0,0,,
45a8db1d-260b-4cdb-9b46-31254ec0ffee,CD68 antibody,,,,,,,PMID:38216587,,Epigenetic reprogramming shapes the cellular landscape of schwannoma,methods,1.0,"CD68 (M0814, Agilent Technologies; labeling validated using human B-cell lymphoma)",Antibody with catalog number not caught,,AI validation - Sonnet 4.5,0,0,,
96d6596c-0d36-4d4c-ac29-d22e17d47b5a,H3K27me3 antibody,,,,,,,PMID:38216572,,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance,methods,1.0,"H3K27me3 (Cell Signaling Technology, #9733, clone C36B11, 1:50 dilution)",Specific antibody with catalog number and vendor clearly mentioned,,AI validation - Sonnet 4.5,0,0,,
daad0d48-1aca-4e01-9a88-a878d96d161b,SOX10 antibody,,,,,,,PMID:38216572,,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance,methods,1.0,"SOX10 (Cell Marque, #383R-1, clone EP268, 1:50 dilution)",Specific antibody with catalog number and vendor clearly mentioned,,AI validation - Sonnet 4.5,0,0,,
da7f4048-6811-4fc6-b24a-a98ae5db9b56,S100B antibody,,,,,,,PMID:38216572,,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance,methods,1.0,"S100B (Ventana, #760-2523, 1:2 dilution)",Specific antibody with catalog number and vendor clearly mentioned,,AI validation - Sonnet 4.5,0,0,,
739f29d7-ac9f-43e8-a6ad-3d389d0e7480,total ERK antibody,,,,,,,PMID:38216572,,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance,methods,1.0,"total ERK (Cell Signaling Technologies, #4695, 1:1000 dilution)",Specific antibody with catalog number and vendor clearly mentioned,,AI validation - Sonnet 4.5,0,0,,
1b0e193e-aefc-437f-8307-968c1bd38a9b,NF2/Merlin antibody,,,,,,,PMID:38216572,,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance,methods,1.0,"NF2/Merlin (Abcam, #ab88957, clone AF1G4, 1:2000 dilution)",Specific antibody with catalog number and vendor clearly mentioned,,AI validation - Sonnet 4.5,0,0,,
4e722023-495f-48ee-b7cf-ab52335b18e6,Iba1 antibody,,,,,,,PMID:30542122,,STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.,abstract,0.9,...Iba1+; F4/80+;CD11b+ macrophages accounted for ~20-40% of proliferating cells...,Antibody marker for cell identification not detected,,AI validation - Sonnet 4.5,0,0,,
46324a1e-444c-4914-a7ec-6a49bb2351b5,S100 antibody,,,,,,,PMID:33591953,,Chromosome 8 gain is associated with high-grade transformation in MPNST.,methods,1.0,"IHC was performed using the Avidin/Biotin blocking kit (Vector Labs, SP-2001) staining with antibodies against S100 (1:250 dilution; catalog ab41548, Abcam)",Antibody with catalog number and vendor not detected,,AI validation - Sonnet 4.5,0,0,,
c0d154ce-5b24-4900-a803-94c4f5b7471e,KI-67 antibody,,,,,,,PMID:33591953,,Chromosome 8 gain is associated with high-grade transformation in MPNST.,methods,1.0,"KI-67 (prediluted; catalog 790-4286, Ventana)",Antibody with catalog number and vendor not detected,,AI validation - Sonnet 4.5,0,0,,
84504af9-784d-4151-b0a2-281d97f5afec,anti-histone H3 (tri methyl K27) antibody,,,,,,,PMID:33591953,,Chromosome 8 gain is associated with high-grade transformation in MPNST.,methods,1.0,"Immunolabeling for anti-histone H3 (tri methyl K27) (1:200 dilution; catalog ab6002, Abcam)",Antibody with catalog number and vendor not detected,,AI validation - Sonnet 4.5,0,0,,
2d11370f-ec4c-478b-b952-a41daaba293b,NF1 antibody,,,,,,,PMID:35740680,,Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors.,methods,1.0,"Primary antibodies used for Western blots were: NF1 (A300-140A, 1:1000, Bethyl Laboratories, Montgomery, TX, USA)",Antibody with catalog number not recognized,,AI validation - Sonnet 4.5,0,0,,
91567a20-d673-419a-94b0-9851c4f8304a,ATRX antibody,,,,,,,PMID:35740680,,Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors.,methods,1.0,"ATRX (#10321, 1:500, Cell Signaling Technology, Danvers, MA, USA)",Antibody with catalog number not recognized,,AI validation - Sonnet 4.5,0,0,,
0d8bf8c1-c105-4192-b7c8-02f6dbdb1893,Erk1/2 antibody,,,,,,,PMID:35740680,,Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors.,methods,1.0,"Erk1/2 (#9102, 1:1000, Cell Signaling Technology)",Antibody with catalog number not recognized,,AI validation - Sonnet 4.5,0,0,,
79fa40d7-dfc8-42f1-abdd-ca39bb58ee56,GFAP antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"glial fibrillary acidic protein (GFAP, DAKO, polyclonal, 1:3,000 dilution, no antigen retrieval)","Specific antibody with vendor (DAKO), dilution, and protocol details clearly indicating research tool usage",,AI validation - Sonnet 4.5,0,0,,
f96b1208-5f59-4096-be86-48616a847422,OLIG2 antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"OLIG2 (Immuno Bio Labs, polyclonal, 1:200 dilution, ER1 antigen retrieval)","Specific antibody with vendor, dilution, and protocol details",,AI validation - Sonnet 4.5,0,0,,
f503a4c6-673b-45c0-a27f-f046deff31bb,SOX10 antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"SOX10 (Cell Marque, clone EP268, dilution 1:250, ER2 antigen retrieval)","Specific antibody with vendor, clone designation, and protocol details",,AI validation - Sonnet 4.5,0,0,,
6a5d0fb9-01f0-4c47-9a3a-93c8f4af8daf,p16 antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"p16 (MTM Labs, clone E6H4, undiluted, ER1 antigen retrieval)","Specific antibody with vendor, clone designation, and protocol details",,AI validation - Sonnet 4.5,0,0,,
288180e1-e06f-4a9c-9674-b5ae689ad417,ATRX antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"ATRX (Sigma, polyclonal, 1:100 dilution)",Specific antibody with vendor and dilution information,,AI validation - Sonnet 4.5,0,0,,
df0c82c5-d610-47eb-97e6-8c9813dd26a7,p53 antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"p53 (Biocare, clone DO-7, 1:100 dilution, ER2 antigen retrieval)","Specific antibody with vendor, clone designation, and protocol details",,AI validation - Sonnet 4.5,0,0,,
388137c4-c756-42b5-9693-5c4e1336cdc1,H3K27me3 antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"histone H3 lysine 27 trimethylation (Cell Signaling, cat #9733, clone C36B11, 1:50 dilution, ER2 antigen retrieval)","Specific antibody with vendor, catalog number, clone, and protocol details",,AI validation - Sonnet 4.5,0,0,,
a8ac449d-88ec-43be-a4c2-98b0fcacfbc5,Ki-67 antibody,,,,,,,PMID:35945463,,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,methods,0.95,"Ki-67 (Dako, clone Mib1, 1:50 dilution, ER2 antigen retrieval)","Specific antibody with vendor, clone designation, and protocol details",,AI validation - Sonnet 4.5,0,0,,
f8f9da1e-bbf4-497b-bdf5-61a4029f058f,IBA1 antibody,,,,,,,PMID:36322658,,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,methods,1.0,"IBA1 (rabbit; Wako Chemicals, 019-19741)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
9a621f34-f7d4-47a7-88e3-eb2d003ff842,CD3 antibody,,,,,,,PMID:36322658,,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,methods,1.0,"CD3 (rat; Bio-Rad, MCA1477)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
faef179a-4e2a-43ae-bc2b-1b5788869e5e,cleaved caspase-3 antibody,,,,,,,PMID:36322658,,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,methods,1.0,"cleaved caspase-3 (rabbit; Cell Signaling Technology, #9661)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
ee6b928f-0543-45b9-99b9-0235707f313b,VEGFA antibody,,,,,,,PMID:36322658,,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,methods,1.0,"VEGFA (rabbit; ABclonal, A0280)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
7b6df7bf-df17-452c-9d36-405523a82e6b,Nestin antibody,,,,,,,PMID:36322658,,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,methods,1.0,"Nestin (mouse; Millipore, MAB353)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
fb060fde-27be-49af-901e-fcbb7e232399,SOX2 antibody,,,,,,,PMID:36322658,,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,methods,1.0,"SOX2 (goat; Santa Cruz Biotechnology, sc-17320)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
02bc30b1-cf8d-4d03-806a-a50a4bdd8e9f,YAP/TAZ antibody,,,,,,,PMID:36322658,,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,methods,1.0,"YAP/TAZ (rabbit; Cell Signaling Technology, #8418)",Antibody with vendor and catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
66ff1184-a654-48d3-bbee-baf504662cd7,ERK1/2 antibody,,,,,,,PMID:36799629,,MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.,methods,1.0,total p44/42 ERK1/2 (4695S; RRID:AB_390779),ERK antibody with catalog number not caught,,AI validation - Sonnet 4.5,0,0,,
b88d28ee-08ba-4ca6-86df-f83245dc4369,Sox9 antibody,,,,,,,PMID:37331503,,Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice.,methods,1.0,"primary antibodies Sox9 (ab185230, Abcam) dilution 1:1 000",Antibody with catalog number and vendor not recognized,,AI validation - Sonnet 4.5,0,0,,
8e45ea5b-0a57-4662-93cd-47532964dc7c,Cleaved Caspase-3 antibody,,,,,,,PMID:37331503,,Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice.,methods,1.0,"Cleaved Caspase-3 (Asp175, Ozyme) dilution 1:200",Specific cleaved form antibody not captured,,AI validation - Sonnet 4.5,0,0,,
cf108aeb-8f45-431c-8bc1-341285897d6a,Ki67 antibody,,,,,,,PMID:37331503,,Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice.,methods,1.0,"Ki67 (ab15580, Abcam) dilution 1:200",Proliferation marker antibody with catalog number not recognized,,AI validation - Sonnet 4.5,0,0,,
13c4a431-173f-442c-927f-e1ed575600d2,PD-L1 antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"PD-L1 (ab213480, Abcam, 66248-1-Ig, Proteintech)",Antibody with multiple catalog numbers not detected,,AI validation - Sonnet 4.5,0,0,,
79daac70-79a8-4753-8efc-e29ff36a2b56,GAPDH antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"GAPDH (SC-32233, Santa Cruz Biotechnology)",Loading control antibody not identified,,AI validation - Sonnet 4.5,0,0,,
cc5fc097-d921-4e98-9e3e-4b708e8deedf,CD3 antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"CD3 (ab16669, Abcam)",IHC antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
946dc56e-3bdf-41e5-a1a7-5bc0c0cc6960,CD4 antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"CD4 (ab183685, Abcam)",IHC antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
64ea5951-5404-4a7d-9bc7-1be3e79d7d03,CD8α antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,CD8α (PA5-81344),IHC antibody with catalog number not detected,,AI validation - Sonnet 4.5,0,0,,
f97543d0-3a1b-4af8-b1ba-443181fe091a,Iba1 antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"Iba1 (019-19741, Thermo Fisher Scientific)",Microglial marker antibody not detected,,AI validation - Sonnet 4.5,0,0,,
a5ccdec7-d39d-4b5a-9806-739b1d70ad44,cleaved caspase 3 antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"cleaved caspase 3 (9661S, Cell Signaling Technology)",Apoptosis marker antibody not detected,,AI validation - Sonnet 4.5,0,0,,
884c7d2c-00e3-46f2-af5c-03e5b6af7784,cleaved PARP antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"cleaved PARP (9488S, Cell Signaling Technology)",Apoptosis marker antibody not detected,,AI validation - Sonnet 4.5,0,0,,
dc5dd392-378a-4cf8-8373-9372bf793ce2,anti-PD-L1 therapeutic antibody,,,,,,,PMID:38502231,,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,methods,1.0,"100 μg mouse monoclonal anti–PD-L1 antibody (BE0146, Bio X Cell)",Therapeutic monoclonal antibody not detected,,AI validation - Sonnet 4.5,0,0,,
e347c060-1b86-4508-aa8f-ecc966a9acf1,anti-merlin antibody,,,,,,,PMID:38945076,,Signaling pathways regulated by nitrated proteins as novel therapeutic targets for neurofibromatosis type 2,methods,1.0,"The absence of merlin in schwannoma cells was confirmed regularly by Western blot (1:2000, Cat. No. 12888, Cell Signaling Technology, Danvers, MA, USA)",Antibody with dilution and catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
954e0e98-77ef-4680-9b35-5408ffca6302,Ki-67 antibody,,,,,,,PMID:38945076,,Signaling pathways regulated by nitrated proteins as novel therapeutic targets for neurofibromatosis type 2,methods,1.0,"Cells were stained with antibodies specific for Ki-67 (1:800 dilution, Cat. no. 9449, Cell Signaling)",Antibody with dilution and catalog number not captured,,AI validation - Sonnet 4.5,0,0,,
8281239a-dff8-4fe0-b927-f35f7c42e522,SOX10 antibody,,,,,,,PMID:38907342,,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response",methods,1.0,...SOX10 at 1:500 dilution (abcam Cat # ab155279) for Schwann cells...,Specific antibody with catalog number and vendor,,AI validation - Sonnet 4.5,0,0,,
79903729-5a08-48e6-9f30-7c8df8d56361,CD34 antibody,,,,,,,PMID:38744290,,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,methods,1.0,CD34 Santa Cruz Biotechnology CAT#SC-74499; RRID: AB_1120394,Clear antibody with catalog number and RRID - should have been detected,,AI validation - Sonnet 4.5,0,0,,
5de623ce-fefc-4fd6-a018-c5b379d35ac0,CD117/c-kit antibody,,,,,,,PMID:38744290,,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,methods,1.0,CD117/c-kit Biocare Medical CAT#CME296AK; RRID: AB_10581782,Antibody with catalog number and RRID,,AI validation - Sonnet 4.5,0,0,,
fc4d673f-17f6-4f8a-9e97-3317fedccc48,NGFR antibody,,,,,,,PMID:38744290,,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,methods,1.0,NGFR Biocare Medical CAT#ACI369A,Antibody with catalog number,,AI validation - Sonnet 4.5,0,0,,
a3c79360-5d6e-460a-8e80-8e56ab5a7fc9,SOX2 antibody,,,,,,,PMID:38744290,,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,methods,1.0,SOX2 Biocare Medical CAT#ACI3109A,Antibody with catalog number,,AI validation - Sonnet 4.5,0,0,,
f865655e-423d-4120-ae26-bbd34ee09cfe,SOX10 antibody,,,,,,,PMID:38744290,,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,methods,1.0,SOX10 Biocare Medical CAT#ACI3099A,Antibody with catalog number,,AI validation - Sonnet 4.5,0,0,,
8bc44edc-5baa-4dd4-81e8-ac4262ac9d00,S100 antibody,,,,,,,PMID:38744290,,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,methods,1.0,S100 Biocare Medical CAT#ACI3237A,Antibody with catalog number,,AI validation - Sonnet 4.5,0,0,,
263b547c-e2a8-4a08-aeea-2ed7d9dcf961,CD163 antibody,,,,,,,PMID:39321200,,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment,abstract,0.9,"...infiltrating myeloid cells, particularly CD163+ tumor-associated macrophages (TAM)...",Antibody target mentioned without explicit 'antibody' keyword - mining likely missed CD163 as a marker requiring antibody detection,,AI validation - Sonnet 4.5,0,0,,
807318fb-40ce-47aa-a616-611b3edda925,PD-L1 antibody,,,,,,,PMID:39321200,,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment,abstract,0.9,"...MPNST specimens demonstrated elevated levels of immunosuppressive TAM, with heightened PD-L1 expression...",PD-L1 expression measurement requires antibody detection but mentioned only as expression level,,AI validation - Sonnet 4.5,0,0,,
af7cd9cb-6bd7-479e-bdb0-69e2365d6a0e,H3K27me3 antibody,,,,,,,PMID:39321200,,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment,results,0.85,...loss of H3K27 trimethylation correlated with low immune cell infiltration in MPNST...,H3K27 trimethylation detection requires specific antibody but mentioned only as epigenetic modification,,AI validation - Sonnet 4.5,0,0,,
4b2463f7-e6f5-4ddd-a9bf-e692e0d16f42,anti-NF1 antibody,,,,,,,PMID:39129390,,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,methods,1.0,"expression of NF1 using Western blotting and an antibody specific for NF1 (Abcam, Cambridge, United Kingdom; ab238142)",Antibody with vendor and catalog number not caught,,AI validation - Sonnet 4.5,0,0,,
0ec6d4b8-d49f-4a80-8092-9e3f4f012a6d,anti-phospho-ERK,,,,,,,PMID:39129390,,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,methods,1.0,"anti‐phospho‐ERK (mouse, Sigma M8159, 1:2500)",Phospho-specific antibody with catalog number,,AI validation - Sonnet 4.5,0,0,,
5f9ace71-4cbd-4239-9b30-e4605b9350b7,anti-PARP,,,,,,,PMID:39129390,,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,methods,1.0,"anti‐PARP (rabbit, Cell Signaling 952, 1: 1000)",PARP antibody with vendor and catalog number,,AI validation - Sonnet 4.5,0,0,,
20724f60-229b-407b-a635-89531bacdf75,CD80,,,,,,,PMID:syn30283982,,Protocol for high-intensity focused ultrasound (HIFU) treatment of cutaneous neurofibromas,abstract,0.9,"Matured DCs (≥ 60% upregulation of CD80, CD86, CD83, and CCR7)",Flow cytometry marker antibodies not detected - likely missing antibody patterns for surface markers,,AI validation - Sonnet 4.5,0,0,,
d3cb9d32-db0e-4a7c-8c0c-61a7960c1e8c,CD86,,,,,,,PMID:syn30283982,,Protocol for high-intensity focused ultrasound (HIFU) treatment of cutaneous neurofibromas,abstract,0.9,"Matured DCs (≥ 60% upregulation of CD80, CD86, CD83, and CCR7)",Flow cytometry marker antibodies not detected - likely missing antibody patterns for surface markers,,AI validation - Sonnet 4.5,0,0,,
640106cd-1ff3-400d-b722-4c508aba8c33,CD83,,,,,,,PMID:syn30283982,,Protocol for high-intensity focused ultrasound (HIFU) treatment of cutaneous neurofibromas,abstract,0.9,"Matured DCs (≥ 60% upregulation of CD80, CD86, CD83, and CCR7)",Flow cytometry marker antibodies not detected - likely missing antibody patterns for surface markers,,AI validation - Sonnet 4.5,0,0,,
8b51398d-bb8b-41f0-8ecc-23f1ffd26167,anti-CD45 antibody,,,,,,,PMID:40684195,,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1,methods,1.0,goat anti-CD45 (1:100; Bio-Techne #AF114),Antibody with catalog number not detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
1e519f32-7ed0-4381-b755-12ea7fbc2b67,anti-Ki67 antibody,,,,,,,PMID:40684195,,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1,methods,1.0,rabbit anti-Ki67 (1:200; Abcam #ab15580),Antibody with catalog number not detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
faf81e73-1ce6-44e7-b666-5ffa7ddad848,anti-P-ERK antibody,,,,,,,PMID:40684195,,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1,methods,1.0,rabbit anti-P-ERK (1:250; Cell Signaling #9101),Antibody with catalog number not detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
f728e16d-6b79-4e7f-8f23-f1d959f4aae5,anti-cKIT antibody,,,,,,,PMID:40684195,,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1,methods,1.0,goat anti-cKIT (1:100; R&D system #AF1356),Antibody with catalog number not detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
f192ca49-0382-40a0-81a8-a1324132251d,anti-MBP antibody,,,,,,,PMID:40684195,,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1,methods,1.0,rat anti-MBP (1:200; Chemicon Millipore #MAB386),Antibody with catalog number not detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
33f7ca9b-755e-4df0-9cb6-74dbab3437a4,anti-nestin antibody,,,,,,,PMID:40684195,,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1,methods,1.0,rabbit anti-nestin (1:100; Abcam # ab221660),Antibody with catalog number not detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
2f6f4cb0-091f-4ee6-8668-8df138d9b88e,anti-S100β antibody,,,,,,,PMID:40684195,,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1,methods,1.0,mouse anti-S100 β (1:300; Abcam #ab218516),Antibody with catalog number not detected by antibody patterns,,AI validation - Sonnet 4.5,0,0,,
